rfhg_169132.1

Basic information about the TSS

---

TSS ID: rfhg_169132.1 Species: human Chr: chr14		Start: 90407193 End: 90407211 Strand: +
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	-
Category:	-

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: BC042831:134 GeneID: 801 HGNC/MGI_ID: HGNC:1442 UniProt_ID: Nearer transcript ids and distances:

Gene_name: calmodulin 1 Gene_symbol: CALM1 Gene_synonyms: CAMI DD132 PHKD PHKD1 Gene_source: HGNC:1442

TATA-Box annotation

---

Distance to TSS:	8952
Nearest PromoterID:	NM_001363670
Entrez ID:	801
Nearest Unigene:	Hs.282410
Nearest Refseq:	NM_006888
Nearest Ensembl:	ENSG00000198668
Gene Name:	calmodulin 1
Gene Alias:	CALML2|CAM2|CAM3|CAMB|CAMC|CAMI|CAMIII|CPVT4|DD132|LQT14|PHKD|caM
Gene Type:	protein-coding
CpG%:	0.055556
GC%:	0.578947
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@CALM1 p5@CALM1 p6@CALM1 p7@CALM1 p8@CALM1 p9@CALM1
Sample		p1@CALM1	p5@CALM1	p6@CALM1	p7@CALM1	p8@CALM1	p9@CALM1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	283.24	2.53	1.75	10.13	3.12	2.34
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	279.40	1.21	1.82	12.95	3.03	2.63
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	269.29	2.70	1.93	11.00	4.05	0.96
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	231.20	3.33	1.46	8.73	1.66	1.87
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	268.16	2.25	2.02	9.45	2.02	0.45
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	261.84	2.13	1.94	13.37	4.07	1.55
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	264.95	1.53	1.74	21.57	4.58	1.96
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	264.99	2.91	0.97	7.27	1.70	0.97
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	250.69	2.99	1.07	5.56	1.50	1.07
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	228.95	5.22	1.16	3.48	1.16	2.32
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	207.37	3.23	0.40	4.45	1.62	1.62
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	219.94	1.22	0.41	2.03	1.22	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	91.88	1.61	0.48	0.97	0.32	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	81.94	2.26	0.30	1.80	0.75	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	90.68	1.32	0.66	1.76	0.22	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	81.48	2.77	0.25	1.51	0.25	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	69.02	3.93	0.22	3.06	0.87	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	71.29	1.69	0.00	1.69	2.11	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	74.11	2.67	0.00	1.07	1.07	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	78.98	2.11	0.30	1.35	0.90	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	89.28	1.07	0.27	1.60	1.07	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	79.23	3.28	0.17	2.59	0.52	1.04
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	78.59	1.16	0.39	1.81	0.90	1.03
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	78.62	2.43	0.00	1.70	1.46	1.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	76.88	3.35	0.26	0.26	1.29	1.03
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	88.31	1.27	0.32	1.90	0.95	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	74.18	1.65	0.55	2.75	0.55	0.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	91.71	1.65	0.24	7.54	3.30	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	69.62	1.45	0.32	1.29	1.13	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	87.41	1.81	0.00	0.72	0.36	0.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	72.43	1.88	0.00	0.63	0.63	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	74.83	1.17	0.00	0.59	0.39	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	79.56	0.63	0.21	1.06	0.84	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	92.53	0.99	0.00	2.80	0.82	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	81.53	1.68	0.56	2.99	0.93	0.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	80.87	1.53	0.00	1.34	0.57	0.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	88.91	1.43	0.41	1.43	0.61	0.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	86.84	3.63	0.00	1.41	0.81	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	116.41	2.97	1.08	2.16	1.08	0.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	104.91	1.44	0.00	2.40	0.72	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	91.05	1.65	1.18	1.18	0.94	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	111.55	1.32	0.44	2.05	0.44	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	92.16	3.59	0.63	2.32	0.84	1.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	99.13	1.57	0.17	0.70	0.35	1.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	122.87	3.21	0.40	2.81	0.80	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	130.05	4.65	0.23	4.19	1.63	1.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	90.68	1.44	0.24	1.68	0.24	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	123.99	2.68	0.30	1.79	1.49	1.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	105.80	1.20	0.24	0.96	0.48	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	98.07	2.22	0.00	1.42	0.40	1.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	79.11	2.87	0.20	3.69	1.43	1.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	95.62	1.33	1.33	4.23	1.33	1.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	587.67	0.00	125.93	69.96	27.98	13.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	100.42	0.35	0.00	2.84	1.06	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	80.86	1.66	0.99	1.33	0.66	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	152.69	0.00	2.52	32.72	6.71	3.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	75.77	0.46	0.92	3.67	1.84	0.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	72.92	0.65	0.00	0.32	0.97	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	83.18	0.96	1.28	2.57	1.93	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	72.61	1.26	1.89	4.71	1.89	1.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	110.69	2.82	0.71	2.82	2.12	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	95.89	1.12	0.56	0.56	1.12	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	159.23	0.00	3.98	21.50	10.35	7.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	108.73	0.00	1.36	2.04	1.02	2.04
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	106.25	0.32	0.97	0.97	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	138.80	0.71	1.77	4.26	0.71	2.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	1115.31	0.00	96.98	177.80	80.82	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	1192.52	15.79	78.97	94.77	55.28	15.79
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	215.48	1.46	0.49	4.88	3.41	1.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	208.27	2.48	1.49	4.96	1.49	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	182.49	0.00	0.94	2.81	0.94	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	153.67	0.33	0.99	3.31	1.32	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	159.00	1.86	1.24	5.88	0.93	0.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	178.25	2.14	0.31	4.28	0.31	0.92
Adipocyte - breast, donor1	11376-118A8	323.74	6.97	2.53	1.58	0.95	1.74
Adipocyte - breast, donor2	11327-117E4	256.84	5.45	2.57	2.25	1.60	0.96
Adipocyte - omental, donor1	11473-119C6	325.70	8.52	1.78	1.78	0.38	1.78
Adipocyte - omental, donor2	11474-119C7	299.74	2.99	0.00	2.99	1.49	1.49
Adipocyte - omental, donor3	11475-119C8	227.75	4.02	0.33	1.00	0.33	1.34
Adipocyte - perirenal, donor1	11476-119C9	297.94	1.91	2.55	3.19	0.64	0.64
Adipocyte - subcutaneous, donor1	11259-116F8	157.23	12.09	0.00	0.00	1.10	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	227.17	9.48	0.90	0.90	0.45	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	133.11	1.91	0.35	0.70	0.35	0.52
Adipocyte differentiation, day04, donor1	13019-139D4	277.32	4.11	1.56	0.59	0.78	0.98
Adipocyte differentiation, day04, donor2	13022-139D7	167.55	0.77	0.77	0.77	0.26	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	263.72	1.67	0.28	0.56	0.56	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	239.83	1.18	0.59	0.59	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	378.44	4.83	1.45	0.64	0.56	0.08
Adipocyte differentiation, day08, donor2	13023-139D8	190.43	1.29	0.65	0.97	0.32	0.32
Adipocyte differentiation, day08, donor3	13026-139E2	171.15	2.13	2.13	0.53	0.53	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	204.21	0.56	2.23	0.56	1.11	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	225.41	2.50	0.00	0.83	0.42	0.83
Adipocyte differentiation, day12, donor2	13024-139D9	189.88	2.26	0.75	1.00	0.50	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	212.38	2.29	0.33	1.96	0.00	0.33
Adipocyte differentiation, day12, donor4	13030-139E6	187.86	1.22	1.52	0.61	0.30	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	223.21	0.66	0.44	0.44	0.22	0.44
Alveolar Epithelial Cells, donor2	11590-120G6	48.41	0.36	0.00	0.00	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	27.55	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	399.39	0.00	1.62	1.98	0.90	0.18
Amniotic Epithelial Cells, donor2	11613-122A2	167.35	0.00	0.00	0.00	3.35	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	184.29	0.82	0.21	1.44	0.41	0.62
Anulus Pulposus Cell, donor1	11248-116E6	224.96	0.80	0.46	0.80	0.80	0.80
Anulus Pulposus Cell, donor2	11463-119B5	181.97	0.00	0.00	0.49	0.49	0.24
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	230.04	0.90	4.94	3.15	0.90	1.80
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	239.65	0.87	2.60	2.60	0.87	0.87
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	214.02	2.14	4.28	4.28	2.14	4.28
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	238.54	0.60	2.99	4.18	1.49	2.09
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	259.25	0.00	2.53	2.53	0.00	1.26
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	173.60	1.32	2.64	4.62	1.98	0.66
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	218.00	0.00	1.95	1.62	0.65	0.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	242.23	0.49	2.91	1.46	1.94	1.94
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	167.47	0.00	2.38	1.19	1.19	2.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	245.57	0.75	1.13	4.14	0.75	2.26
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	243.83	0.73	1.45	0.00	0.00	0.73
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	162.99	5.02	3.76	5.02	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	268.68	0.49	1.32	1.15	0.16	0.33
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	271.60	4.09	0.00	0.00	1.36	1.36
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	195.27	0.45	1.06	0.60	0.45	0.30
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	259.32	0.54	2.68	3.21	0.00	2.14
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	245.43	0.38	2.27	1.13	0.19	0.57
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	217.30	1.60	3.47	3.47	1.07	1.07
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	268.25	1.95	1.95	2.93	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	238.67	1.00	3.32	1.66	0.00	0.83
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	195.72	0.00	3.60	0.00	0.00	2.40
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	240.73	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	240.66	0.00	2.06	2.23	0.51	0.51
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	142.63	0.00	0.00	4.19	0.00	4.19
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	226.21	0.49	3.88	3.40	0.00	1.46
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	236.40	0.38	1.14	1.90	0.76	1.90
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	187.76	0.00	2.42	1.21	1.21	1.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	235.42	0.57	3.42	2.28	0.00	1.14
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	227.46	0.21	1.71	0.86	0.43	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	174.21	0.77	2.84	1.29	0.26	0.26
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	225.22	0.00	0.94	1.88	0.94	0.94
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	252.74	0.00	2.89	1.61	0.32	1.61
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	181.93	0.00	1.43	2.14	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	242.75	0.00	2.92	2.34	0.00	2.34
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	248.99	0.00	1.20	0.90	0.30	0.60
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	175.82	0.00	1.19	2.38	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	234.95	1.02	3.05	5.09	1.02	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	228.20	0.76	2.55	2.55	1.02	1.27
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	166.47	0.00	1.27	2.54	0.00	1.27
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	246.41	0.00	3.45	0.86	0.43	1.29
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	240.48	0.21	1.91	0.64	0.85	0.42
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	176.89	0.00	2.32	2.61	0.29	1.16
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	262.64	0.00	2.83	2.83	0.00	0.94
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	232.25	0.17	1.19	1.70	0.34	0.68
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	189.94	0.00	4.63	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	276.75	0.00	2.11	6.34	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	256.22	0.64	1.50	2.36	0.00	1.50
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	203.96	0.00	2.41	0.60	0.60	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	207.76	0.00	2.19	2.92	2.19	0.73
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	236.55	0.69	1.84	2.99	0.69	0.23
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	170.87	2.55	0.00	17.85	0.00	2.55
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	219.15	0.76	1.27	1.53	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	257.84	0.62	2.48	1.45	0.21	0.62
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	186.05	0.00	1.22	1.84	1.53	2.45
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	264.34	0.48	2.87	1.43	0.48	3.35
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	227.95	0.67	3.33	2.00	0.67	0.89
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	183.10	0.00	0.00	1.53	0.00	1.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	231.53	1.11	3.88	1.11	0.55	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	244.41	1.32	3.97	1.06	0.79	0.79
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	161.37	0.73	2.54	1.09	1.09	1.82
Astrocyte - cerebellum, donor1	11500-119F6	156.22	0.12	0.00	0.98	0.00	0.25
Astrocyte - cerebellum, donor2	11580-120F5	99.96	0.00	0.17	0.51	0.34	0.00
Astrocyte - cerebellum, donor3	11661-122F5	29.78	0.00	0.42	0.00	0.00	0.42
Astrocyte - cerebral cortex, donor1	11235-116D2	618.39	2.09	6.97	2.44	1.39	2.09
Astrocyte - cerebral cortex, donor2	11316-117D2	484.19	1.13	2.75	2.10	0.81	1.29
Astrocyte - cerebral cortex, donor3	11392-118C6	509.98	1.19	1.49	2.98	1.04	0.89
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	283.27	2.06	0.23	1.15	0.69	0.46
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	317.34	1.38	0.50	2.00	0.63	0.38
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	317.49	1.14	0.11	1.14	0.91	1.14
Basophils, donor1	12241-129G9	379.22	0.00	1.83	0.78	0.26	0.26
Basophils, donor2	12242-129H1	846.06	0.36	6.13	3.25	0.00	0.72
Basophils, donor3	12243-129H2	415.27	0.73	1.32	0.44	0.15	0.44
Bronchial Epithelial Cell, donor1	11511-119G8	144.67	0.22	0.22	0.00	0.00	0.22
Bronchial Epithelial Cell, donor2	11591-120G7	66.29	0.00	0.00	0.46	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	279.77	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	252.94	0.00	0.00	0.00	0.00	0.63
Bronchial Epithelial Cell, donor5	11457-119A8	196.31	0.62	0.21	0.62	0.42	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	194.13	0.92	0.00	0.69	0.00	0.46
Bronchial Epithelial Cell, donor7	11769-123I5	227.09	0.72	1.98	3.24	1.08	0.72
Burkitt's lymphoma cell line:DAUDI	10422-106C8	287.42	0.41	1.65	0.52	0.41	0.62
Burkitt's lymphoma cell line:RAJI	10476-106I8	298.35	0.93	1.16	0.93	0.93	0.93
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	192.50	0.00	0.64	0.00	0.00	0.32
CD133+ stem cells - cord blood derived, pool1	12223-129E9	310.26	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	260.36	0.00	2.25	0.56	0.00	0.56
CD14+ Monocytes, donor2	11305-117B9	325.17	0.37	0.93	2.60	0.19	0.37
CD14+ Monocytes, donor3	11381-118B4	331.50	1.32	1.98	2.20	0.66	0.88
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	401.92	4.25	0.85	0.85	0.85	0.28
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	503.79	9.48	1.52	0.76	0.00	1.14
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	430.98	3.29	1.97	0.33	0.99	0.99
CD14+ monocytes - mock treated, donor1	11863-125A9	176.64	2.60	1.01	1.59	1.16	1.01
CD14+ monocytes - mock treated, donor2	11873-125C1	159.92	2.72	0.91	1.21	0.00	0.30
CD14+ monocytes - mock treated, donor3	11883-125D2	211.78	1.66	0.95	0.47	0.47	0.95
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	160.03	0.84	0.50	2.85	0.17	0.50
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	171.13	0.55	0.83	0.55	0.55	0.83
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	210.00	0.74	0.50	1.24	0.00	0.50
CD14+ monocytes - treated with BCG, donor1	11860-125A6	188.95	0.20	0.78	2.94	0.39	0.98
CD14+ monocytes - treated with BCG, donor2	11870-125B7	222.20	0.53	1.60	1.42	0.18	0.36
CD14+ monocytes - treated with BCG, donor3	11880-125C8	326.01	0.44	1.09	3.05	0.65	1.09
CD14+ monocytes - treated with Candida, donor1	11868-125B5	178.64	2.81	0.47	0.94	0.94	1.17
CD14+ monocytes - treated with Candida, donor2	11878-125C6	238.14	1.58	0.00	1.58	0.00	0.53
CD14+ monocytes - treated with Candida, donor3	11888-125D7	261.81	3.33	0.00	0.00	0.00	1.11
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	159.90	2.83	1.04	0.89	0.59	0.30
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	161.23	1.80	0.40	1.60	0.60	0.60
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	223.61	0.21	0.62	1.04	0.83	0.83
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	219.40	3.43	1.60	2.06	0.46	1.14
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	203.36	3.39	0.45	1.36	0.23	0.45
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	243.11	5.67	0.00	2.18	0.44	0.87
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	219.50	0.54	0.81	0.27	0.00	0.54
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	248.78	1.57	1.74	2.27	0.17	1.05
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	316.46	2.10	1.26	2.95	0.84	0.84
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	189.41	0.55	0.55	3.31	1.10	0.37
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	214.18	0.00	0.00	1.76	0.35	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	262.36	0.00	0.44	1.32	0.88	0.44
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	192.86	1.74	1.57	1.39	0.70	0.52
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	229.32	1.12	1.12	5.58	1.12	1.12
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	318.58	1.08	0.65	1.72	1.29	0.22
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	220.71	0.00	0.41	2.87	0.41	0.41
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	230.41	0.00	0.93	0.70	0.23	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	253.10	0.00	0.93	1.62	0.70	0.46
CD14+CD16+ Monocytes, donor1	11789-124B7	416.09	1.74	0.65	3.05	0.87	0.87
CD14+CD16+ Monocytes, donor2	11801-124D1	429.19	4.39	1.15	1.85	1.15	0.92
CD14+CD16+ Monocytes, donor3	11912-125G4	444.28	1.30	1.08	0.65	0.22	0.87
CD14+CD16- Monocytes, donor1	11788-124B6	445.99	3.11	1.40	0.78	0.78	1.40
CD14+CD16- Monocytes, donor2	11799-124C8	353.65	2.79	1.22	1.57	0.35	0.52
CD14+CD16- Monocytes, donor3	11910-125G2	398.00	0.67	0.45	0.67	0.22	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	442.22	0.77	1.28	1.53	0.26	0.51
CD14-CD16+ Monocytes, donor2	11800-124C9	490.07	4.61	0.44	3.29	0.88	0.66
CD14-CD16+ Monocytes, donor3	11911-125G3	519.84	2.95	1.47	1.26	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	504.01	0.00	0.00	0.00	2.03	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	498.99	2.03	0.68	1.36	0.68	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	527.12	1.04	2.07	0.00	1.04	1.04
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	543.17	2.67	3.73	0.53	0.53	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	570.91	1.61	1.61	1.61	0.00	0.54
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	476.62	0.00	2.11	0.70	0.00	0.70
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	522.38	4.71	1.57	2.35	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	552.36	1.32	1.32	0.00	0.00	1.32
CD19+ B Cells, donor1	11544-120B5	586.01	6.58	2.47	2.47	0.00	2.47
CD19+ B Cells, donor2	11624-122B4	582.52	0.73	2.90	6.53	1.45	1.45
CD19+ B Cells, donor3	11705-123B4	591.66	5.05	1.01	4.04	1.01	1.01
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	142.63	0.00	0.81	0.40	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	109.46	0.00	0.40	0.00	0.00	0.40
CD34+ Progenitors, donor1	11545-120B6	144.58	0.00	0.00	1.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	408.43	0.00	0.56	1.12	0.00	0.56
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	278.81	0.00	1.13	0.75	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	223.00	0.00	0.45	0.68	0.00	0.00
CD4+ T Cells, donor1	11225-116C1	1128.30	2.50	6.07	4.64	2.50	1.79
CD4+ T Cells, donor2	11306-117C1	1075.31	1.84	7.96	15.92	4.90	4.90
CD4+ T Cells, donor3	11382-118B5	1222.72	1.52	8.23	15.86	4.57	3.35
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	1186.59	14.55	1.53	5.10	3.57	7.15
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	1036.74	5.84	4.72	4.72	2.70	2.25
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	922.17	3.74	3.45	4.60	2.59	2.59
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	1189.02	2.84	5.22	1.90	1.90	0.95
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	1115.29	1.40	3.51	4.21	0.70	2.81
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	1064.68	3.30	3.30	3.30	0.00	3.30
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	1053.95	16.76	2.31	5.20	2.02	4.48
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	923.23	6.27	6.61	8.13	2.54	2.71
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	750.74	4.35	7.25	7.09	2.26	2.10
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	1378.52	10.31	6.28	4.03	1.34	2.69
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	1330.82	6.64	3.14	6.29	1.05	3.14
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	1040.12	4.40	3.52	5.28	2.20	0.44
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	920.86	8.01	2.53	3.79	2.95	1.69
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	707.87	3.95	6.23	4.16	1.66	2.49
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	598.42	1.67	6.01	4.68	0.67	1.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	1061.36	2.72	3.54	4.89	1.63	1.90
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	1048.32	6.43	5.36	3.22	0.54	1.61
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	925.30	1.79	1.79	5.38	0.00	5.38
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	1417.23	8.16	4.26	5.56	2.60	3.15
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	1202.44	8.01	2.38	4.77	2.82	2.82
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	1127.67	11.98	2.52	3.78	1.68	2.73
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	1258.96	3.54	1.01	5.56	0.51	1.52
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	1237.37	6.07	3.47	5.63	1.73	1.73
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	1174.52	3.49	2.61	10.02	2.18	1.31
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	1297.05	0.99	4.95	2.47	1.98	1.48
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	1273.07	1.85	2.77	0.92	0.00	0.92
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	1394.43	2.79	0.00	2.79	0.00	2.79
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	1557.72	4.15	0.28	2.77	0.83	1.66
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	1680.44	3.19	0.74	3.68	1.47	0.49
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	1398.33	0.00	1.54	0.00	0.00	1.54
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	1222.26	3.58	4.66	3.22	2.51	0.72
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	1415.46	0.00	4.15	2.77	0.00	1.38
CD8+ T Cells, donor1	11226-116C2	1280.77	6.55	9.49	5.24	2.62	2.95
CD8+ T Cells, donor2	11307-117C2	1142.06	3.00	10.14	18.40	4.51	6.01
CD8+ T Cells, donor3	11383-118B6	1066.51	2.02	9.85	9.85	4.80	3.53
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	207.83	0.46	1.61	14.45	4.36	1.84
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	183.33	0.48	0.48	12.46	2.88	2.40
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	198.63	0.27	1.09	13.13	5.75	1.92
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	255.78	0.00	0.90	11.71	2.70	0.60
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	205.43	0.24	0.96	7.20	0.96	1.92
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	193.96	0.91	1.14	5.68	1.59	2.27
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	225.76	0.65	1.09	15.43	3.26	1.09
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	225.57	0.26	1.32	10.53	1.84	1.58
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	244.13	0.00	0.70	9.15	2.58	0.94
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	258.41	0.91	1.51	14.19	2.72	2.42
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	203.93	0.58	0.87	13.07	2.91	1.16
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	195.83	0.27	0.27	8.26	1.60	1.87
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	168.10	0.44	0.44	1.75	1.31	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	179.44	0.00	0.46	0.91	0.46	0.46
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	200.64	0.00	0.00	1.49	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	194.48	1.08	0.36	2.88	0.36	0.72
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	200.54	1.15	1.15	3.16	1.15	0.86
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	182.19	1.89	0.71	2.83	0.24	0.47
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	198.06	0.32	1.27	10.46	2.54	2.54
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	186.38	0.62	0.92	4.31	0.92	0.62
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	185.62	1.60	0.64	2.24	0.64	0.64
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	161.02	0.00	0.38	8.03	1.15	2.29
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	174.19	0.00	0.39	3.94	1.58	0.39
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	195.91	0.00	0.76	6.05	6.05	1.51
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	222.42	0.00	0.80	0.80	0.80	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	207.73	0.70	0.70	3.50	0.70	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	135.24	0.00	3.01	6.01	3.01	0.00
Cardiac Myocyte, donor1	11525-119I4	126.11	0.00	0.00	1.83	3.66	0.00
Cardiac Myocyte, donor2	11605-120I3	221.85	0.00	0.49	0.99	0.00	1.48
Cardiac Myocyte, donor3	11686-122I3	423.67	0.32	0.63	0.74	0.53	0.42
Chondrocyte - de diff, donor1	11261-116G1	348.75	4.85	1.39	2.43	1.04	0.00
Chondrocyte - de diff, donor2	11338-117F6	189.42	2.84	1.07	1.07	0.36	0.71
Chondrocyte - de diff, donor3	11410-118E6	187.05	0.80	1.59	0.91	0.34	0.80
Chondrocyte - re diff, donor2	11339-117F7	651.75	7.16	0.00	0.90	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	227.68	1.21	0.40	1.21	0.81	0.40
Ciliary Epithelial Cells, donor1	11242-116D9	303.31	1.03	1.61	1.49	1.26	0.57
Ciliary Epithelial Cells, donor2	11323-117D9	250.75	1.28	1.71	2.99	0.64	0.43
Ciliary Epithelial Cells, donor3	11399-118D4	255.40	0.80	1.42	1.77	0.62	0.80
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	735.44	5.41	3.39	3.30	1.28	1.28
Corneal Epithelial Cells, donor1	11526-119I5	122.74	0.66	0.22	0.44	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	175.19	0.00	0.00	2.28	1.14	0.00
Corneal Epithelial Cells, donor3	11687-122I4	166.93	0.26	0.00	0.26	0.26	0.51
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	574.20	3.30	5.78	3.30	0.66	0.99
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	571.84	1.89	7.25	2.84	0.32	0.63
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	634.93	0.00	3.45	3.45	3.45	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	611.55	1.73	3.46	3.89	2.05	1.62
Dendritic Cells - plasmacytoid, donor1	11228-116C4	397.67	1.02	1.37	1.02	0.34	0.68
Dendritic Cells - plasmacytoid, donor2	11309-117C4	445.26	0.00	0.65	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	495.08	0.48	0.00	0.97	0.48	0.48
Endothelial Cells - Aortic, donor0	11207-116A1	513.31	0.33	1.00	0.50	0.00	0.33
Endothelial Cells - Aortic, donor1	11263-116G3	343.85	2.35	0.59	2.35	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	458.13	0.28	1.13	1.70	0.00	0.28
Endothelial Cells - Aortic, donor3	11412-118E8	332.63	0.79	0.79	0.39	0.79	0.00
Endothelial Cells - Artery, donor1	11264-116G4	278.95	2.91	0.29	1.16	0.58	0.29
Endothelial Cells - Artery, donor2	11341-117F9	520.67	4.47	2.82	4.71	1.18	2.35
Endothelial Cells - Artery, donor3	11413-118E9	422.14	2.63	1.23	1.05	0.18	0.88
Endothelial Cells - Lymphatic, donor1	11236-116D3	404.07	2.44	2.44	2.22	1.33	1.55
Endothelial Cells - Lymphatic, donor2	11317-117D3	481.05	2.74	0.91	1.52	0.61	2.13
Endothelial Cells - Lymphatic, donor3	11393-118C7	929.72	5.64	0.56	1.69	1.69	0.56
Endothelial Cells - Microvascular, donor1	11265-116G5	475.71	6.24	0.89	2.08	1.49	1.49
Endothelial Cells - Microvascular, donor2	11342-117G1	379.04	3.12	1.04	0.52	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	314.06	3.40	1.28	2.98	1.28	0.99
Endothelial Cells - Thoracic, donor1	11266-116G6	837.05	4.80	0.80	2.40	0.40	2.00
Endothelial Cells - Thoracic, donor2	11343-117G2	383.66	1.57	0.52	1.57	1.05	2.10
Endothelial Cells - Umbilical vein, donor1	11243-116E1	696.28	3.60	2.61	3.60	1.37	0.75
Endothelial Cells - Umbilical vein, donor2	11324-117E1	402.80	0.43	0.65	0.43	0.00	0.22
Endothelial Cells - Umbilical vein, donor3	11400-118D5	535.29	0.73	0.49	1.10	0.24	0.37
Endothelial Cells - Vein, donor1	11267-116G7	341.25	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	426.09	2.10	0.00	2.10	0.70	0.00
Endothelial Cells - Vein, donor3	11416-118F3	507.45	1.26	1.88	2.04	1.41	0.94
Eosinophils, donor1	12244-129H3	1402.72	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	922.50	1.65	0.00	4.95	1.65	0.00
Eosinophils, donor3	12246-129H5	838.20	3.57	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	141.71	0.00	0.00	0.49	0.00	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	70.73	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	309.11	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	258.62	1.64	3.28	1.23	0.82	1.23
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	181.53	10.07	0.99	6.79	4.27	2.85
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	268.14	6.07	0.65	8.45	1.95	2.28
Fibroblast - Aortic Adventitial, donor1	11245-116E3	393.43	7.16	0.85	2.67	1.46	1.21
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	328.35	1.50	0.96	0.41	0.27	0.14
Fibroblast - Aortic Adventitial, donor2	11326-117E3	263.04	4.11	1.37	2.32	0.63	1.16
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	221.07	2.63	0.00	2.11	0.26	1.05
Fibroblast - Aortic Adventitial, donor3	11401-118D6	398.64	3.99	1.00	4.32	1.99	1.33
Fibroblast - Cardiac, donor1	11268-116G8	227.72	0.45	0.00	2.72	0.00	0.45
Fibroblast - Cardiac, donor2	11345-117G4	331.98	1.52	0.00	3.03	0.00	0.76
Fibroblast - Cardiac, donor3	11417-118F4	144.15	1.58	0.63	0.95	0.00	0.63
Fibroblast - Cardiac, donor4	11452-119A3	286.44	1.21	0.00	0.00	0.30	0.30
Fibroblast - Cardiac, donor5	11456-119A7	336.93	0.89	0.63	1.27	0.63	0.76
Fibroblast - Cardiac, donor6	11460-119B2	419.92	0.91	0.91	0.91	1.52	1.06
Fibroblast - Choroid Plexus, donor1	11492-119E7	200.18	0.54	0.00	0.00	0.13	0.27
Fibroblast - Choroid Plexus, donor2	11572-120E6	188.53	0.00	0.86	0.00	0.43	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	383.78	0.00	0.00	8.79	0.00	2.93
Fibroblast - Conjunctival, donor1	11531-120A1	154.30	0.00	0.00	0.23	0.00	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	232.87	1.19	0.34	1.19	0.85	0.34
Fibroblast - Dermal, donor1	11269-116G9	282.44	4.46	0.23	0.47	0.70	0.94
Fibroblast - Dermal, donor2	11346-117G5	387.25	1.42	0.00	0.47	0.94	0.00
Fibroblast - Dermal, donor3	11418-118F5	259.91	2.18	0.85	1.57	0.73	0.73
Fibroblast - Dermal, donor4	11450-119A1	409.68	0.68	0.34	1.70	0.79	0.57
Fibroblast - Dermal, donor5	11454-119A5	457.77	0.52	0.70	2.44	0.52	0.70
Fibroblast - Dermal, donor6	11458-119A9	561.98	0.49	0.49	1.79	0.32	0.16
Fibroblast - Gingival, donor1	11237-116D4	413.34	1.46	2.29	2.08	0.00	0.83
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	443.04	3.67	0.00	1.31	1.05	1.31
Fibroblast - Gingival, donor2	11318-117D4	412.62	0.79	3.43	3.43	0.92	0.79
Fibroblast - Gingival, donor3	11394-118C8	310.85	1.55	0.29	0.48	0.58	0.39
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	225.44	1.04	0.00	1.04	1.04	1.04
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	198.58	2.29	0.70	2.47	1.06	0.00
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	515.71	1.71	0.94	1.71	1.56	1.40
Fibroblast - Gingival, donor6 (control)	11922-125H5	475.19	1.76	0.27	3.38	1.22	0.41
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	402.28	1.76	0.00	0.00	0.35	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	451.46	1.17	0.58	3.22	1.17	0.88
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	491.01	1.64	0.95	1.64	1.09	0.68
Fibroblast - Gingival, donor8 (control)	11926-125H9	416.61	1.86	0.99	1.97	1.43	0.77
Fibroblast - Gingival, donor9 (control)	11927-125I1	269.56	3.23	0.29	1.76	0.59	0.15
Fibroblast - Lung, donor1	11270-116H1	148.17	1.36	0.00	1.36	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	308.88	1.49	0.00	2.98	0.00	2.98
Fibroblast - Lung, donor3	11419-118F6	273.29	0.63	0.42	0.42	0.42	0.63
Fibroblast - Lymphatic, donor1	11506-119G3	208.26	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	170.63	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	38.62	0.00	0.28	0.00	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	319.90	1.22	0.00	0.41	0.00	0.00
Fibroblast - Mammary, donor2	11620-122A9	75.89	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	166.78	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	549.33	1.36	3.49	2.52	0.19	1.36
Fibroblast - Periodontal Ligament, donor2	11319-117D5	498.12	1.06	0.76	2.28	0.61	0.46
Fibroblast - Periodontal Ligament, donor3	11395-118C9	639.82	0.61	0.31	0.31	1.53	0.61
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	359.11	0.38	1.14	1.53	0.38	0.38
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	359.36	1.35	4.32	2.43	1.08	0.27
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	239.37	0.46	0.46	0.70	0.23	0.35
Fibroblast - Pulmonary Artery, donor1	11250-116E8	451.42	1.33	3.43	1.77	0.77	0.99
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	232.04	0.61	0.20	0.61	0.20	0.41
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	132.30	0.00	0.00	0.00	0.67	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	286.24	0.40	1.58	1.19	0.00	0.40
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	311.36	0.60	0.00	0.79	0.40	0.99
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	290.41	1.78	0.53	1.60	0.71	1.95
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	365.40	0.59	0.20	1.58	0.99	0.59
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	297.24	0.90	0.00	1.20	0.60	0.90
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	457.93	1.08	0.11	3.13	0.43	0.32
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	277.62	0.51	0.25	2.28	0.51	0.76
Fibroblast - skin normal, donor1	11553-120C5	359.99	1.15	0.82	2.79	1.15	0.49
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	339.06	1.20	1.40	1.40	0.80	0.60
Fibroblast - skin normal, donor2	11561-120D4	487.24	1.81	0.10	2.51	1.21	0.70
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	367.22	0.00	0.00	3.32	0.00	1.81
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	280.19	1.33	1.08	0.58	0.33	1.08
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	432.16	1.20	0.00	1.88	1.37	1.03
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	307.41	0.66	0.66	2.96	0.33	0.66
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	519.40	1.07	0.11	1.92	0.43	0.75
Fibroblast - skin walker warburg, donor1	11554-120C6	446.16	1.52	1.01	2.19	0.84	0.67
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	249.81	0.47	0.78	9.10	2.82	0.63
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	2792.13	22.16	22.16	310.24	44.32	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	291.96	1.74	0.87	0.87	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	505.86	5.55	1.04	1.73	0.69	1.04
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	580.60	5.99	0.52	1.30	0.78	2.34
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	542.20	5.62	1.02	1.28	0.51	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	349.86	16.84	0.77	3.83	0.77	1.53
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	361.15	10.85	3.19	2.55	3.83	3.19
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	512.05	5.71	5.13	5.99	3.71	1.43
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	380.82	12.96	4.41	2.21	6.34	0.55
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	473.09	22.60	2.74	4.57	3.88	1.60
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	392.89	6.54	1.78	5.55	3.17	1.98
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	340.73	11.37	3.97	4.23	4.76	1.85
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	566.84	12.07	3.26	3.26	1.63	1.63
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	388.71	2.65	1.77	8.40	0.88	0.44
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	383.83	2.12	0.28	3.53	0.42	0.85
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	332.36	0.74	0.86	3.20	1.60	0.62
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	372.31	1.34	1.34	3.49	0.27	2.15
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	367.34	2.11	0.62	2.60	1.24	1.24
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	357.42	1.38	0.83	2.08	0.83	0.83
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	290.52	3.66	1.63	3.46	0.81	1.22
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	311.69	3.65	2.51	0.46	0.91	1.14
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	323.37	1.49	1.00	2.87	0.75	0.50
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	306.44	1.53	0.22	1.53	0.66	0.44
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	279.82	4.73	1.48	1.18	0.59	0.89
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	328.57	0.95	0.64	5.88	0.79	1.11
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	299.16	2.46	0.89	2.23	0.45	1.12
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	328.06	2.62	1.81	2.62	1.41	1.41
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	436.83	1.53	1.87	3.56	0.68	1.02
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	438.22	6.03	1.24	1.42	0.44	1.33
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	374.91	3.75	1.14	0.42	0.62	0.52
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	397.57	3.07	0.17	0.51	0.34	0.34
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	352.54	0.66	0.22	2.77	0.33	0.33
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	390.86	3.83	2.00	0.92	0.75	0.83
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	402.64	2.45	0.61	0.41	0.00	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	273.56	3.30	2.06	1.65	0.41	2.06
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	289.27	0.81	0.81	3.23	1.04	0.81
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	318.02	2.00	1.50	2.17	1.33	1.17
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	251.95	4.41	1.98	2.20	1.10	0.88
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	292.11	2.71	0.25	1.97	0.61	0.74
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	320.78	2.59	1.13	2.27	0.97	1.30
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	209.11	3.53	1.28	1.60	0.32	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	340.26	1.14	1.14	2.94	0.76	0.66
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	308.13	3.48	1.27	1.58	0.32	0.32
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	302.26	5.78	2.74	2.74	2.43	1.22
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	394.63	2.82	1.36	3.24	0.94	1.25
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	252.93	2.63	0.88	2.63	0.66	0.88
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	307.48	4.21	2.81	1.68	0.84	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	396.55	1.48	0.56	2.50	0.65	1.85
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	366.61	2.94	1.60	2.14	1.34	0.80
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	482.27	3.06	2.75	3.67	1.99	0.77
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	445.87	1.81	1.68	3.24	0.65	0.39
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	314.72	1.08	0.81	0.00	0.54	0.54
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	295.51	1.66	2.21	3.13	0.74	0.55
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	250.46	1.97	1.75	1.10	0.66	1.75
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	197.36	1.98	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	296.54	1.98	2.11	1.85	1.06	0.66
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	273.78	1.61	1.82	1.41	0.61	1.01
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	247.04	0.25	1.78	0.25	0.00	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	530.69	2.19	0.20	2.19	1.19	1.59
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	340.66	0.92	0.77	2.62	0.31	1.54
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	487.11	1.02	0.82	2.45	1.23	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	409.94	2.82	0.63	1.88	0.31	0.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	403.21	4.24	1.41	1.41	0.57	1.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	456.59	3.69	2.31	3.69	1.38	0.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	428.14	4.95	0.00	7.42	4.95	7.42
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	514.07	6.58	1.93	1.16	2.32	1.93
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	492.57	1.60	4.81	6.42	1.60	4.81
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	434.71	0.00	0.00	6.96	1.74	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	501.89	8.46	3.25	2.60	1.63	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	452.98	4.53	1.65	3.29	1.65	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	353.22	10.00	0.00	29.99	3.33	6.66
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	437.09	4.47	1.68	2.80	0.84	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	431.43	4.58	0.65	0.98	1.31	1.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	302.82	3.36	0.00	15.94	12.58	2.52
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	406.50	7.32	1.91	1.27	1.27	0.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	374.65	4.42	1.36	2.72	2.38	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	415.54	4.18	2.09	6.26	0.00	2.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	351.06	1.72	2.86	1.15	1.15	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	260.17	1.78	2.07	2.07	0.89	0.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	325.28	1.69	1.69	13.55	5.08	1.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	408.82	3.31	3.31	3.73	1.66	0.83
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	353.48	3.91	2.07	0.92	0.92	0.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	342.45	0.00	0.00	21.07	0.00	10.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	329.06	1.54	3.08	0.77	0.38	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	315.87	4.56	1.96	2.28	0.33	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	325.06	4.68	0.67	0.67	0.67	1.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	319.00	6.16	0.39	3.47	0.77	2.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	346.79	6.50	2.74	1.03	1.37	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	231.09	7.45	2.48	2.48	0.00	7.45
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	263.29	5.66	2.36	3.30	0.00	0.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	318.04	4.22	0.60	1.81	1.81	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	288.42	4.58	1.02	2.03	0.51	0.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	347.39	5.98	3.19	0.80	0.40	1.99
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	337.46	5.92	1.97	1.97	0.99	1.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	271.50	2.36	2.36	4.72	1.18	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	280.64	2.92	2.33	1.75	0.00	1.75
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	324.77	2.19	1.32	1.76	0.00	1.76
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	244.14	0.00	3.39	4.24	0.85	2.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	225.63	0.60	2.39	2.98	1.19	1.79
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	277.56	4.37	0.97	2.91	0.49	1.46
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	141.52	0.00	1.14	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	168.82	1.66	0.42	2.08	0.83	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	257.50	1.12	0.00	2.25	0.00	1.12
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	157.63	0.32	1.27	0.95	0.32	0.32
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	168.35	0.84	2.51	0.42	0.00	1.25
Hep-2 cells mock treated, biol_rep1	11898-125E8	271.19	1.39	0.81	1.62	0.81	1.04
Hep-2 cells mock treated, biol_rep2	11899-125E9	291.52	0.34	0.34	2.70	0.51	1.01
Hep-2 cells mock treated, biol_rep3	11900-125F1	301.67	0.23	0.91	3.87	0.68	0.68
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	274.37	1.97	0.98	2.62	0.66	1.09
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	284.97	0.86	1.07	1.50	0.43	0.43
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	280.30	0.65	0.65	1.08	0.43	0.22
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	270.62	1.37	1.25	2.99	1.12	0.87
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	252.18	0.86	1.20	1.03	0.51	0.34
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	243.48	0.64	0.32	4.16	0.64	0.96
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	247.35	1.68	0.00	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	66.22	1.30	0.00	0.87	0.00	0.43
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	383.35	2.64	5.29	7.93	0.00	7.93
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	136.15	0.35	0.00	0.00	0.35	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	79.92	0.00	0.00	0.00	0.00	0.73
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	308.94	0.70	1.40	2.10	0.87	0.70
Hepatocyte, donor1	11523-119I2	355.92	2.42	6.05	7.26	1.21	2.42
Hepatocyte, donor2	11603-120I1	284.42	2.15	1.08	1.08	2.15	1.08
Hepatocyte, donor3	11684-122I1	265.05	5.52	1.23	1.23	0.61	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	245.41	0.65	3.92	0.00	0.00	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	638.65	4.54	3.50	3.85	0.52	1.75
Iris Pigment Epithelial Cells, donor1	11530-119I9	287.59	0.41	0.55	0.69	0.55	0.27
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	35.02	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	20.03	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	27.08	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	33.23	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	17.52	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	94.95	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	43.57	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	45.71	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	27.61	0.00	0.00	1.62	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	50.02	0.00	0.00	1.67	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	29.04	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	59.56	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	38.80	0.00	0.00	1.11	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	31.43	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	44.72	0.00	0.00	0.63	0.00	0.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	40.21	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	35.53	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	30.59	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	11.95	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	38.30	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	23.51	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	57.49	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	45.01	0.80	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	36.93	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	45.24	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	49.56	0.00	0.00	0.47	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	44.44	0.00	0.00	0.00	0.00	0.91
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	44.23	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	55.96	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	34.30	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	32.86	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	35.07	0.00	0.00	0.64	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	41.92	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	15.80	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	30.70	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	33.18	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	62.55	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	48.77	0.00	0.31	0.00	0.93	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	29.85	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	37.72	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	31.29	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	26.56	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	42.15	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	17.44	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	38.25	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	17.42	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	21.34	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	33.25	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	31.35	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	28.53	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	9.08	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	12.42	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	24.32	0.00	1.06	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	244.31	3.59	0.82	0.82	0.24	1.14
Keratinocyte - epidermal, donor2	11349-117G8	142.31	1.17	0.00	0.59	0.00	0.59
Keratinocyte - epidermal, donor3	11421-118F8	380.14	0.85	1.33	5.49	0.66	1.04
Keratinocyte - oral, donor1	11251-116E9	351.00	0.57	0.91	1.14	0.91	0.34
Keratocytes, donor1	11527-119I6	116.56	0.34	0.00	0.34	0.00	0.00
Keratocytes, donor2	11607-120I5	119.52	1.17	0.00	1.17	0.00	0.00
Keratocytes, donor3	11688-122I5	157.88	0.40	0.79	1.58	0.59	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	268.15	0.00	2.20	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	310.68	1.08	0.00	1.08	0.00	1.08
Lens Epithelial Cells, donor2	11609-120I7	257.19	0.12	0.35	0.35	0.23	0.23
Lens Epithelial Cells, donor3	11690-122I7	300.21	0.30	0.30	0.50	0.20	0.30
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	453.32	3.32	1.30	2.25	0.83	0.83
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	277.96	0.84	1.12	3.07	1.40	1.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	402.19	1.73	1.89	7.56	2.68	2.05
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	336.07	2.69	1.61	3.23	0.54	1.08
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	275.14	1.58	2.21	1.26	2.21	0.63
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	270.29	0.97	2.05	2.48	0.86	2.05
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	377.15	0.82	3.28	1.64	0.82	0.41
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	202.26	0.51	1.52	1.01	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	272.77	1.83	1.97	5.91	0.70	0.99
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	256.70	1.58	3.16	1.58	0.00	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	235.18	0.97	1.36	2.33	1.16	0.58
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	176.63	0.00	1.11	2.41	0.19	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	375.95	1.05	4.53	3.14	2.09	2.44
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	243.77	0.72	1.19	2.39	0.72	0.48
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	253.82	1.37	2.06	4.53	1.24	1.24
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	290.40	0.31	1.85	1.54	0.00	0.62
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	183.93	0.00	1.56	1.87	1.25	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	284.92	1.83	1.83	2.20	1.10	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	339.64	1.65	1.32	5.27	0.66	1.32
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	181.58	0.00	0.88	2.93	0.59	0.59
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	205.12	1.49	1.24	1.74	1.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	354.02	1.45	1.94	3.88	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	232.40	0.27	0.81	2.42	0.27	1.35
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	291.40	1.51	1.51	1.21	0.76	0.76
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	276.31	1.56	2.59	2.59	1.04	0.52
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	271.16	0.63	2.51	2.30	0.63	0.84
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	268.26	1.50	1.95	2.86	0.60	1.50
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	275.84	0.69	1.38	1.38	0.69	0.69
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	211.67	0.94	2.07	1.32	1.13	0.56
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	220.33	0.74	1.59	1.91	0.64	0.53
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	298.50	0.00	1.45	2.91	0.00	1.45
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	184.91	1.98	0.66	0.66	0.33	0.66
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	215.08	1.36	1.73	4.09	0.99	1.24
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	334.30	1.85	2.59	1.11	0.74	1.11
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	213.97	0.25	1.98	2.47	0.25	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	210.64	0.55	1.51	2.06	1.24	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	347.69	1.61	3.86	2.25	0.64	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	257.16	0.61	1.52	2.13	0.30	0.91
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	331.30	1.54	1.96	4.20	1.12	0.56
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	339.56	1.07	3.56	2.84	0.71	0.71
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	142.04	0.00	0.48	1.94	0.48	0.48
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	162.92	1.09	0.62	1.87	0.62	0.78
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	292.21	0.72	1.07	1.79	0.72	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	187.18	0.33	0.33	0.33	0.33	0.33
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	164.09	0.00	1.65	1.41	0.47	0.47
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	352.57	2.35	0.74	0.62	0.25	1.11
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	123.71	0.51	0.51	1.79	0.00	0.26
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	221.68	1.49	0.30	2.98	0.60	0.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	246.99	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	247.78	1.53	1.53	0.77	0.00	0.77
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	221.18	0.74	0.00	0.74	1.48	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	166.29	0.85	0.85	0.85	0.85	0.42
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	206.78	1.41	1.41	0.00	0.00	0.70
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	159.71	0.93	0.00	0.93	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	144.79	0.52	1.03	2.58	1.03	0.52
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	157.01	0.00	0.00	2.38	1.19	1.19
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	189.32	0.90	0.23	0.68	0.00	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	287.92	1.16	1.45	5.53	0.29	3.78
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	337.63	2.70	2.25	4.95	0.90	1.35
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	221.65	1.49	0.41	1.22	0.27	0.81
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	187.95	0.51	2.05	3.08	0.51	1.03
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	312.98	0.71	1.06	2.12	1.41	2.12
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	298.50	2.67	0.00	0.00	0.00	0.67
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	211.40	0.51	1.53	4.08	1.02	2.55
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	348.45	2.13	1.60	3.47	0.53	0.80
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	325.36	0.76	1.89	3.78	1.51	2.46
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	202.48	0.61	2.45	2.45	1.23	1.23
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	276.43	4.89	0.00	1.63	0.00	0.82
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	326.94	1.25	2.08	4.16	0.62	2.29
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	313.33	2.24	3.08	6.45	1.40	2.80
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	255.52	0.00	2.06	0.00	0.00	1.03
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	317.59	1.45	5.81	6.39	2.32	3.48
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	314.47	0.60	3.59	3.59	0.30	2.09
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	351.32	2.21	0.55	1.11	2.21	1.66
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	210.32	1.41	2.12	1.77	0.35	1.06
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	254.46	1.11	1.11	3.69	0.74	1.11
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	185.36	0.00	0.00	1.15	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	223.34	0.00	0.38	0.00	0.38	0.77
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	191.92	0.57	1.13	3.40	1.13	3.40
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	283.06	0.00	2.46	1.64	0.82	0.82
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	205.61	0.45	0.90	4.07	0.90	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	249.20	1.44	1.44	4.31	0.72	2.15
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	326.40	2.24	0.00	2.24	0.00	0.75
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	232.25	0.37	0.37	1.86	0.74	1.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	324.78	0.86	1.72	2.15	0.86	1.29
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	280.01	0.00	0.86	4.28	0.86	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	273.54	1.33	1.33	3.33	1.33	3.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	248.56	0.00	0.00	0.00	0.60	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	238.18	2.13	0.00	0.71	0.71	1.42
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	224.10	1.37	0.34	2.41	0.69	0.69
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	240.46	0.54	0.00	3.22	1.07	1.61
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	222.21	2.02	0.67	0.67	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	250.03	0.37	2.59	2.59	1.48	2.59
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	281.43	0.00	0.00	1.16	0.00	2.33
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	205.20	0.00	1.06	0.00	0.00	1.06
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	218.08	0.80	1.20	3.60	0.80	0.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	159.91	0.00	0.00	1.45	0.73	1.45
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	209.26	0.77	0.77	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	184.49	0.49	0.00	2.96	0.49	0.99
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	170.31	0.00	0.94	0.94	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	210.18	0.00	1.51	0.50	0.50	1.01
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	193.32	0.45	0.45	0.90	0.45	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	151.46	0.00	0.00	0.00	1.72	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	199.96	0.89	0.89	1.34	0.89	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	200.21	0.78	0.39	1.96	1.17	0.78
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	168.23	0.00	0.66	2.64	0.66	1.98
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	211.20	0.00	0.52	2.08	0.00	0.52
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	209.16	0.88	0.88	2.63	0.88	0.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	246.00	0.56	1.12	2.24	0.00	1.68
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	219.05	1.32	2.65	1.32	1.32	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	229.50	1.93	1.54	1.93	0.77	1.16
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	208.11	1.01	1.01	4.05	0.51	0.51
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	226.85	0.96	1.44	1.44	0.96	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	240.52	0.00	1.19	2.39	1.59	0.80
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	223.60	0.61	1.22	2.43	0.61	1.22
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	183.30	0.69	0.00	0.69	2.08	2.08
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	229.89	1.52	1.14	1.90	1.52	1.14
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	205.02	1.55	2.07	4.65	0.52	1.55
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	200.14	0.60	0.00	0.60	1.21	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	226.27	0.63	2.22	3.49	0.63	0.95
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	169.52	0.53	0.53	1.60	0.53	2.13
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	187.92	1.15	0.57	1.15	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	196.44	0.51	0.51	4.63	1.03	1.54
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	230.60	0.71	0.71	2.83	0.71	1.41
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	185.57	0.57	0.57	2.27	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	225.90	0.83	1.25	2.50	0.42	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	220.82	0.00	1.57	0.00	0.78	0.78
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	233.41	0.42	0.42	2.09	0.42	1.25
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	215.59	0.93	1.86	1.39	0.46	1.39
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	230.15	0.67	0.67	3.35	0.67	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	271.60	0.00	1.07	2.67	1.07	0.53
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	217.40	0.00	0.00	2.83	0.40	0.81
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	228.52	0.00	0.92	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	251.62	1.78	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	238.21	0.57	0.57	0.57	1.14	1.71
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	222.40	0.77	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	304.23	1.09	0.55	3.28	1.64	0.55
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	241.43	0.00	0.00	3.12	0.45	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	265.41	1.56	1.04	1.04	0.26	0.52
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	250.65	1.33	0.66	3.32	0.00	0.66
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	241.12	6.24	0.00	0.00	0.00	4.16
Macrophage - monocyte derived, donor1	11232-116C8	517.60	1.14	3.65	3.19	1.14	1.37
Macrophage - monocyte derived, donor2	11313-117C8	394.17	1.28	2.20	1.10	0.92	1.10
Macrophage - monocyte derived, donor3	11389-118C3	433.49	0.92	1.57	1.31	0.79	0.92
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	516.15	0.00	1.06	0.53	0.00	0.53
Mallassez-derived cells, donor2	11929-125I3	430.83	1.11	0.79	3.64	0.79	0.63
Mallassez-derived cells, donor3	11930-125I4	592.50	1.67	1.53	3.06	0.97	0.28
Mammary Epithelial Cell, donor1	11273-116H4	335.20	0.90	1.10	1.69	0.20	0.50
Mammary Epithelial Cell, donor2	11350-117G9	312.13	0.58	0.00	3.19	0.29	0.29
Mammary Epithelial Cell, donor3	11422-118F9	173.85	0.50	0.25	0.25	0.50	0.00
Mast cell - stimulated, donor1	11487-119E2	1216.22	0.00	3.39	0.68	0.68	0.00
Mast cell, donor1	11563-120D6	550.76	7.35	0.76	0.87	0.76	1.08
Mast cell, donor2	11565-120D8	638.03	28.83	2.97	2.38	1.49	4.16
Mast cell, donor3	11566-120D9	593.65	18.69	2.93	0.68	0.68	3.83
Mast cell, donor4	11567-120E1	684.34	24.47	2.48	1.06	1.77	4.43
Mast cell, expanded and stimulated, donor5	11940-126A5	456.99	5.66	1.22	3.11	1.22	1.00
Mast cell, expanded and stimulated, donor8	11942-126A7	759.95	19.26	2.33	4.09	1.17	4.09
Mast cell, expanded, donor5	11939-126A4	408.30	12.73	1.49	1.72	1.03	1.72
Mast cell, expanded, donor8	11941-126A6	349.13	10.38	0.67	1.67	0.50	1.34
Melanocyte - dark, donor1	11502-119F8	598.68	1.49	1.49	1.59	0.80	0.80
Melanocyte - dark, donor2	11582-120F7	213.88	0.69	0.69	2.08	0.35	1.04
Melanocyte - dark, donor3	11663-122F7	739.19	1.01	3.77	1.74	0.58	1.38
Melanocyte - light, donor1	11274-116H5	195.82	6.82	0.24	0.94	0.71	0.24
Melanocyte - light, donor2	11351-117H1	247.73	8.87	0.68	1.36	0.00	2.05
Melanocyte - light, donor3	11423-118G1	153.50	1.73	0.00	0.87	0.87	0.87
Melanocyte, donor1 (MC+1)	12641-134G4	413.59	1.98	2.71	2.39	0.83	0.52
Melanocyte, donor2 (MC+2)	12739-135I3	440.53	2.15	5.92	3.50	0.81	1.61
Melanocyte, donor3 (MC+3)	12837-137B2	398.30	2.14	1.07	1.34	0.54	0.27
Meningeal Cells, donor1	11493-119E8	410.27	0.50	0.12	0.25	0.00	0.50
Meningeal Cells, donor2	11573-120E7	314.71	0.88	0.88	0.88	0.00	0.00
Meningeal Cells, donor3	11654-122E7	512.24	1.14	1.96	2.28	0.73	0.49
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	354.16	0.57	3.14	0.57	0.29	0.86
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	129.71	0.91	0.91	0.50	0.00	0.40
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	39.42	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	66.72	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	379.61	0.00	1.44	4.31	0.72	1.44
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	263.02	2.54	0.64	0.42	0.64	0.42
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	221.67	2.01	1.51	1.51	0.00	1.51
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	194.70	0.22	0.00	1.76	0.44	0.44
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	189.95	0.00	0.00	1.46	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	134.83	0.20	0.82	1.02	0.20	0.41
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	281.72	0.83	0.14	0.69	0.14	0.42
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	55.02	0.37	0.00	0.37	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	202.76	0.39	0.53	1.71	0.13	0.13
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	114.84	0.59	0.30	2.08	0.30	0.30
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	44.38	0.00	0.00	2.34	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	167.78	0.64	0.00	1.92	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	436.32	1.06	4.96	1.42	0.00	1.42
Mesenchymal stem cells - hepatic, donor0	11218-116B3	172.31	0.00	1.25	0.00	0.31	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	365.02	0.00	0.73	0.00	0.00	0.73
Mesothelial Cells, donor1	11247-116E5	229.11	2.39	2.92	0.53	0.27	0.80
Mesothelial Cells, donor2	12156-128G5	250.23	0.50	1.00	0.00	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	218.60	1.30	0.87	3.83	0.72	0.51
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	193.10	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	380.74	0.99	2.96	1.48	0.00	0.99
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	287.69	1.47	0.88	0.88	0.59	0.29
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	76.06	0.00	0.00	3.46	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	322.65	0.62	3.10	1.55	0.93	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	240.00	0.41	1.66	4.77	1.87	1.24
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	88.01	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	353.37	1.00	2.00	2.50	0.50	1.50
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	296.51	0.93	0.00	0.00	0.47	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	116.80	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	300.56	0.81	1.22	1.83	0.41	0.61
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	256.98	0.00	0.79	2.77	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	68.41	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	236.28	0.88	0.00	0.88	0.00	1.77
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	308.89	0.00	2.28	3.04	1.90	1.90
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	63.16	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	275.26	0.21	1.91	1.91	0.85	0.42
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	158.38	0.00	0.92	0.00	0.00	0.92
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	273.02	0.00	2.38	1.19	0.30	0.89
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	117.37	0.00	0.00	1.68	0.00	1.68
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	101.85	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	332.20	1.25	4.01	3.51	1.00	1.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	279.02	0.71	0.24	3.33	0.95	0.24
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	110.02	0.00	1.11	0.55	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	422.04	1.38	3.45	3.68	0.00	2.07
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	281.85	0.21	1.05	3.16	1.26	0.63
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	267.22	0.41	1.02	1.02	0.41	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	389.17	1.29	3.22	2.15	1.29	1.07
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	292.09	0.00	0.89	1.33	0.22	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	113.50	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	445.92	1.31	3.94	1.97	0.66	1.10
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	261.08	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	137.53	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	479.98	1.09	4.08	2.17	0.27	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	338.20	0.29	0.59	1.76	0.59	0.59
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	152.65	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	449.80	1.92	1.92	1.44	1.44	0.96
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	349.00	1.20	0.80	2.00	0.80	2.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	209.80	0.00	1.37	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	598.69	1.50	2.00	5.01	3.50	1.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	323.37	0.00	26.95	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	220.16	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	690.60	2.19	1.75	3.50	0.88	1.75
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	204.18	0.00	2.21	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	224.78	0.00	0.64	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	807.97	2.23	4.71	4.21	2.23	1.74
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	349.34	0.00	0.70	0.70	0.70	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	229.83	0.00	0.00	2.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	569.57	2.39	3.76	4.10	2.74	3.42
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	335.21	0.00	0.44	0.88	0.00	0.44
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	248.21	0.00	2.13	0.71	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	705.59	2.52	4.77	2.24	3.09	1.96
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	438.49	0.00	0.42	2.08	0.42	0.42
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	206.29	0.00	1.75	0.00	0.00	0.58
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	548.13	1.81	3.92	3.92	0.00	1.51
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	525.91	0.42	2.92	2.50	0.42	0.42
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	129.94	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	394.36	0.92	2.77	2.77	2.77	1.85
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	575.38	0.57	2.85	2.28	1.14	0.57
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	286.73	0.41	0.14	0.97	0.41	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	524.00	2.07	2.33	3.11	0.26	1.04
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	429.83	0.43	0.00	0.43	1.29	0.86
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	139.11	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	400.60	0.53	1.60	1.60	1.87	0.53
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	467.25	1.20	1.50	3.29	0.60	0.30
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	186.88	0.14	0.14	0.71	0.71	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	443.69	0.96	2.87	3.50	1.27	0.32
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	481.40	0.88	0.88	2.43	0.66	0.44
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	183.53	0.38	0.38	0.76	0.38	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	434.40	1.14	1.42	2.27	0.57	1.14
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	530.69	0.49	2.21	4.67	3.20	1.23
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	105.57	0.00	0.65	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	310.79	0.88	1.18	1.18	0.59	0.88
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	374.82	1.73	0.58	2.02	0.58	0.29
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	278.61	1.65	0.82	1.24	0.41	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	289.74	1.19	0.60	1.79	0.30	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	290.05	0.00	7.53	0.00	3.77	3.77
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	272.68	0.00	7.13	5.35	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	321.67	1.31	1.31	4.27	2.30	1.97
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	365.03	3.16	1.05	5.26	1.05	2.10
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	278.34	2.37	0.99	1.38	0.40	0.40
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	366.94	1.86	1.86	1.86	0.00	1.86
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	404.07	4.51	3.76	9.39	3.38	1.13
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	323.34	1.33	2.40	1.60	0.53	0.80
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	305.49	0.34	0.00	0.68	0.11	0.34
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	223.96	2.21	0.00	3.68	1.47	1.47
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	288.38	2.56	1.10	2.56	2.20	1.10
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	326.68	7.78	7.78	20.22	3.11	3.11
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	458.01	0.53	0.00	0.53	0.00	0.53
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	220.24	0.00	0.00	0.00	0.00	3.86
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	245.42	0.00	1.01	5.05	0.00	2.02
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	436.82	2.95	0.00	3.79	1.26	1.26
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	686.42	2.72	0.00	1.36	0.00	1.36
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	558.86	0.00	0.00	0.64	0.00	0.64
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	737.76	0.00	0.00	1.62	1.62	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	506.00	9.06	0.00	4.53	0.00	3.02
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	930.76	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	766.68	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	769.90	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	514.51	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	491.19	1.72	2.37	1.51	1.08	1.72
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	229.95	0.00	1.57	0.52	0.00	0.52
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	182.89	1.33	0.67	1.33	0.00	0.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	198.67	0.83	0.83	0.83	0.83	0.42
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	237.68	0.00	0.38	3.04	1.71	0.57
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	336.72	0.00	0.00	1.60	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	113.55	0.00	0.00	1.36	0.00	1.36
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	757.11	0.00	5.51	20.21	9.19	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	103.38	0.42	0.00	0.42	0.84	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	159.22	0.70	0.23	0.70	0.93	0.23
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	135.11	0.54	0.27	1.08	0.27	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	205.19	0.00	0.21	0.63	0.84	0.63
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	1503.19	11.13	33.40	55.67	11.13	11.13
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	163.30	2.98	0.00	0.99	0.99	1.49
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	118.01	0.54	0.54	2.71	0.81	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	107.45	0.23	0.68	1.81	0.68	0.45
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	136.52	1.31	0.33	1.14	0.98	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	227.64	0.91	0.55	1.64	0.18	0.55
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	141.63	2.12	0.53	3.18	0.00	0.53
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	89.45	0.60	0.00	1.20	0.00	1.20
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	148.34	0.33	0.66	4.92	2.63	0.66
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	93.51	0.81	0.81	0.65	0.33	0.33
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	306.38	0.53	0.53	1.06	0.53	0.18
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	184.95	1.41	0.00	0.70	1.41	2.11
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	93.32	0.00	0.46	0.00	0.00	0.46
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	115.68	0.96	0.64	0.96	0.32	0.32
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	231.76	0.34	1.72	2.41	1.03	1.38
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	1385.59	2.53	0.00	17.70	12.64	2.53
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	281.60	1.34	1.34	0.89	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	143.11	0.00	1.27	4.66	0.42	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	106.81	0.24	0.47	0.95	0.47	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	146.80	0.43	0.43	0.43	0.43	0.43
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	1706.25	9.03	9.03	18.06	9.03	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	148.62	0.33	0.67	0.67	0.00	0.67
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	252.48	0.00	0.45	0.90	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	150.39	0.79	0.40	1.19	0.40	0.79
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	143.94	0.93	0.00	2.79	0.93	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	138.48	0.38	2.27	1.89	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	131.66	0.33	0.33	0.33	0.33	0.33
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	104.15	0.00	0.44	0.44	0.44	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	341.02	0.90	1.81	1.36	1.36	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	125.23	1.76	0.00	3.53	0.88	0.88
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	134.96	2.66	0.66	0.00	0.00	2.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	162.70	0.00	0.00	1.49	0.00	0.99
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	112.17	0.00	0.38	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	122.49	0.30	0.00	1.81	0.60	0.30
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	248.87	0.22	0.44	0.44	0.44	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	109.10	0.68	0.00	1.36	0.68	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	1389.79	5.11	20.44	20.44	15.33	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	137.79	0.61	0.00	1.22	0.00	0.61
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	88.44	0.31	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	91.70	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	122.63	0.79	0.79	2.37	0.79	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	190.45	1.13	0.00	3.40	2.27	2.27
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	1143.08	0.00	25.29	55.64	15.17	5.06
Myoblast, donor1	11241-116D8	313.18	0.62	2.86	2.24	1.24	1.12
Myoblast, donor2	11322-117D8	277.71	1.15	1.73	2.69	0.58	1.15
Myoblast, donor3	11398-118D3	331.28	1.68	0.67	1.68	0.17	0.34
NK T cell leukemia cell line:KHYG-1	10777-110G3	514.41	1.61	2.48	4.23	1.75	1.17
Natural Killer Cells, donor1	11230-116C6	1145.50	8.30	7.38	3.69	1.23	2.15
Natural Killer Cells, donor2	11311-117C6	1019.56	5.73	8.44	14.47	3.02	2.11
Natural Killer Cells, donor3	11387-118C1	945.30	5.52	7.73	7.91	2.02	2.58
Neural stem cells, donor1	11275-116H6	1403.49	37.75	2.18	3.27	2.18	3.99
Neural stem cells, donor2	11352-117H2	1971.86	13.48	0.00	0.00	0.00	0.00
Neurons, donor1	11494-119E9	787.43	0.00	7.97	1.14	2.28	2.28
Neurons, donor2	11574-120E8	1020.24	3.30	10.35	5.50	1.10	1.32
Neurons, donor3	11655-122E8	522.08	1.64	3.29	5.76	2.47	1.64
Neutrophils, donor1	11233-116C9	657.03	50.11	1.86	9.28	2.78	3.71
Neutrophils, donor2	11314-117C9	452.22	46.38	2.90	11.60	0.00	2.90
Neutrophils, donor3	11390-118C4	1099.52	76.97	0.61	2.44	2.44	0.61
Nucleus Pulposus Cell, donor1	11252-116F1	137.26	0.59	0.47	0.12	0.00	0.47
Nucleus Pulposus Cell, donor2	11409-118E5	136.10	0.00	0.00	0.98	0.33	0.65
Nucleus Pulposus Cell, donor3	11462-119B4	208.57	0.20	0.40	0.60	0.20	0.20
Olfactory epithelial cells, donor1	11933-125I7	195.05	1.38	0.96	1.93	0.96	0.14
Olfactory epithelial cells, donor2	11934-125I8	228.70	0.72	3.18	4.78	1.74	1.74
Olfactory epithelial cells, donor3	11935-125I9	203.06	0.57	2.38	2.04	0.34	0.34
Olfactory epithelial cells, donor4	11936-126A1	257.71	0.58	2.24	1.85	0.58	0.39
Oligodendrocyte - precursors, donor1	11496-119F2	522.98	0.00	1.81	1.81	0.60	1.20
Osteoblast - differentiated, donor1	11276-116H7	247.36	4.68	0.43	0.00	0.00	1.06
Osteoblast - differentiated, donor2	11353-117H3	118.88	3.43	0.00	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	129.11	1.86	0.00	0.00	0.00	0.00
Osteoblast, donor1	11277-116H8	200.91	0.78	0.59	0.20	0.20	0.59
Osteoblast, donor2	11354-117H4	460.02	0.70	0.70	2.11	0.00	0.00
Osteoblast, donor3	11426-118G4	273.53	0.53	1.42	0.89	0.00	0.00
Pancreatic stromal cells, donor1	11249-116E7	286.99	3.29	1.60	1.85	0.34	0.51
Pericytes, donor1	11491-119E6	39.61	0.00	0.11	0.22	0.00	0.00
Pericytes, donor2	11571-120E5	100.73	0.00	0.00	0.23	0.23	0.23
Pericytes, donor3	11652-122E5	127.77	0.20	1.22	0.00	0.20	0.20
Perineurial Cells, donor1	11499-119F5	373.08	0.34	1.81	1.24	0.23	0.23
Perineurial Cells, donor2	11579-120F4	321.58	0.83	0.37	0.83	0.18	0.55
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	801.31	3.19	1.59	1.27	1.59	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	420.43	2.69	3.92	2.69	1.71	1.71
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	618.22	1.42	1.68	2.33	1.68	1.42
Placental Epithelial Cells, donor1	11278-116H9	120.30	0.72	0.24	0.00	0.24	0.00
Placental Epithelial Cells, donor2	11355-117H5	217.34	3.33	1.11	1.11	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	116.62	0.39	0.00	0.39	0.20	0.20
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	218.99	3.16	0.32	9.49	2.22	2.85
Preadipocyte - breast, donor1	11467-119B9	208.79	2.81	0.75	0.56	0.00	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	295.38	0.78	0.91	0.26	0.26	0.65
Preadipocyte - breast, donor2	11328-117E5	231.00	2.25	1.80	1.58	0.90	1.35
Preadipocyte - omental, donor1	11468-119C1	235.28	3.73	1.17	0.96	0.75	1.28
Preadipocyte - omental, donor2	11329-117E6	354.41	1.75	0.44	1.31	1.75	0.87
Preadipocyte - omental, donor3	11403-118D8	322.45	1.43	2.44	2.01	0.72	0.43
Preadipocyte - perirenal, donor1	11469-119C2	180.12	0.00	0.98	0.98	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	178.13	1.84	0.00	0.00	0.00	0.31
Preadipocyte - subcutaneous, donor2	11356-117H6	505.02	0.53	1.95	3.19	1.24	0.71
Preadipocyte - subcutaneous, donor3	11428-118G6	366.62	3.07	1.53	1.53	0.68	0.51
Preadipocyte - visceral, donor1	11280-116I2	523.21	6.15	1.68	1.49	0.37	1.02
Preadipocyte - visceral, donor2	11357-117H7	421.53	3.68	1.84	4.14	0.92	0.92
Preadipocyte - visceral, donor3	11429-118G7	311.07	1.88	1.25	1.88	0.21	0.42
Prostate Epithelial Cells (polarized), donor1	11253-116F2	461.00	18.86	2.56	3.02	2.11	1.81
Prostate Epithelial Cells, donor2	11331-117E8	301.30	5.96	0.95	1.35	0.81	0.68
Prostate Epithelial Cells, donor3	11404-118D9	290.51	4.90	0.86	3.61	1.71	1.04
Prostate Stromal Cells, donor1	11254-116F3	309.58	2.28	1.71	3.19	0.34	0.80
Prostate Stromal Cells, donor2	11332-117E9	402.70	0.72	1.08	4.12	1.26	0.72
Prostate Stromal Cells, donor3	11405-118E1	232.33	4.80	0.31	1.67	0.83	0.52
Renal Cortical Epithelial Cells, donor1	11516-119H4	152.56	0.36	0.00	0.73	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	417.95	1.39	1.87	2.77	0.62	1.32
Renal Epithelial Cells, donor1	11517-119H5	79.13	0.51	0.00	0.00	0.00	1.01
Renal Epithelial Cells, donor2	11597-120H4	125.90	0.71	0.71	0.71	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	448.97	2.12	1.27	3.28	0.42	0.64
Renal Glomerular Endothelial Cells, donor1	11514-119H2	122.55	0.68	0.00	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	217.37	0.40	0.13	0.94	0.27	0.40
Renal Glomerular Endothelial Cells, donor3	11675-122H1	541.93	0.89	1.78	7.77	4.44	0.89
Renal Glomerular Endothelial Cells, donor4	11783-124B1	70.54	0.00	0.00	0.67	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	142.62	0.22	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor2	11598-120H5	122.26	0.00	1.25	1.88	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	50.21	0.28	0.00	0.00	0.00	0.28
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	370.42	0.54	0.00	1.07	0.00	0.27
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	136.63	0.42	0.00	1.27	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	161.22	0.39	1.16	0.39	0.58	0.58
Retinal Pigment Epithelial Cells, donor0	11215-116A9	324.10	0.52	2.07	0.00	1.30	0.52
Retinal Pigment Epithelial Cells, donor1	11528-119I7	120.80	1.42	0.85	0.57	0.00	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	78.21	0.00	0.00	0.00	1.03	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	120.44	1.76	1.00	0.50	0.00	0.50
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	672.72	14.30	3.21	1.47	0.94	1.20
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	162.60	1.79	0.89	2.68	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	138.14	7.15	0.00	1.10	1.65	1.10
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	175.76	0.00	0.00	0.58	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	289.96	0.13	0.00	0.91	0.26	0.26
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	194.54	0.79	0.10	0.89	0.40	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	257.43	1.34	0.89	1.00	0.45	0.78
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	322.76	0.87	0.37	1.74	0.37	1.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	201.74	1.40	0.58	2.45	0.35	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	225.82	1.85	0.46	3.47	0.00	1.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	239.73	0.00	0.14	0.96	0.41	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	188.64	1.51	0.61	1.66	0.30	0.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	227.75	0.18	0.72	0.36	0.18	0.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	251.05	0.57	0.57	1.86	0.86	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	191.02	1.07	0.21	1.40	0.43	0.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	209.98	0.66	0.00	0.66	0.22	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	242.22	0.57	0.38	0.19	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	192.66	0.28	0.65	1.12	0.56	0.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	253.30	2.07	0.56	1.50	0.19	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	229.72	0.53	0.00	0.53	0.00	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	194.58	0.68	0.49	0.88	0.19	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	224.76	0.38	0.19	1.15	0.76	0.95
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	233.56	0.32	0.00	0.32	0.21	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	168.18	0.56	1.12	0.84	0.84	0.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	205.93	0.68	0.34	1.54	0.34	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	219.53	0.00	0.18	0.36	0.55	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	195.60	0.61	0.49	1.96	0.25	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	223.64	0.54	1.07	1.07	0.54	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	295.55	1.18	0.24	0.94	0.47	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	190.68	0.60	0.20	1.79	0.79	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	217.71	0.23	0.00	1.17	0.00	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	269.77	0.62	0.41	2.07	0.00	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	206.61	0.22	0.22	2.88	0.44	0.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	191.13	0.42	0.84	0.84	0.21	0.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	274.42	0.27	0.13	1.62	0.27	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	182.73	0.17	0.00	0.34	0.34	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	203.59	0.39	0.39	1.16	0.19	0.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	279.40	1.55	0.34	1.03	0.52	0.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	187.78	0.41	0.41	0.96	0.27	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	204.06	0.49	0.82	1.64	0.33	0.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	251.04	0.17	0.17	1.02	0.34	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	225.64	1.63	0.44	1.04	0.59	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	205.24	0.27	0.00	0.53	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	170.62	0.55	0.00	0.41	0.14	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	204.29	0.71	0.24	0.71	0.48	0.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	213.43	0.20	0.40	0.00	0.00	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	201.44	1.60	0.19	1.04	0.47	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	182.02	4.89	0.00	1.05	0.35	1.05
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	138.11	0.30	0.30	0.91	0.60	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	248.69	4.04	0.12	0.61	0.49	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	265.20	2.47	1.02	0.73	0.58	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	194.09	6.69	1.22	0.00	1.83	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	244.13	5.12	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	185.02	5.65	0.23	0.68	0.23	0.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	206.68	3.89	0.60	0.90	0.30	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	188.21	7.67	0.00	0.59	0.35	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	198.93	19.21	0.00	0.21	0.85	1.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	206.14	7.21	0.60	1.80	0.00	1.20
Schwann Cells, donor1	11498-119F4	122.81	0.00	0.00	0.00	0.00	0.19
Schwann Cells, donor2	11578-120F3	285.80	6.80	3.40	3.40	3.40	0.00
Schwann Cells, donor3	11659-122F3	323.80	0.66	1.31	3.72	0.88	0.88
Sebocyte, donor1	11220-116B5	281.55	0.55	0.55	0.00	0.00	0.00
Sebocyte, donor2	11301-117B5	197.15	1.84	0.46	0.46	0.46	0.00
Sebocyte, donor3	11378-118B1	130.47	1.44	0.62	0.62	0.21	0.00
Sertoli Cells, donor1	11255-116F4	374.39	6.63	3.31	1.66	3.31	0.00
Sertoli Cells, donor2	11333-117F1	327.63	5.65	0.00	2.82	2.82	0.00
Skeletal Muscle Cells, donor1	11281-116I3	344.26	6.07	2.64	1.50	0.35	0.79
Skeletal Muscle Cells, donor2	11358-117H8	123.61	1.45	0.00	0.00	0.00	0.72
Skeletal Muscle Cells, donor3	11430-118G8	240.78	0.00	0.84	0.00	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	339.64	0.63	0.16	1.41	0.47	0.47
Skeletal Muscle Cells, donor5	11455-119A6	323.75	1.19	0.45	2.38	0.45	1.04
Skeletal Muscle Cells, donor6	11459-119B1	490.64	0.62	0.92	1.69	1.08	0.77
Skeletal Muscle Satellite Cells, donor1	11240-116D7	317.16	1.76	1.13	1.51	0.88	0.50
Skeletal Muscle Satellite Cells, donor2	11321-117D7	283.24	1.00	1.00	2.28	0.57	0.57
Skeletal Muscle Satellite Cells, donor3	11397-118D2	496.84	1.29	2.28	3.17	0.50	1.19
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	613.02	4.55	4.63	2.27	1.01	0.67
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	209.89	0.72	2.17	0.72	0.72	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	202.27	0.55	0.69	1.38	0.41	0.14
Skin - palm, donor1	10286-104F7	231.01	0.00	2.69	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	211.33	2.02	0.86	6.92	2.16	0.86
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	241.28	0.82	0.00	4.09	0.82	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	228.76	1.17	0.65	3.64	1.17	0.78
Small Airway Epithelial Cells, donor1	11256-116F5	413.97	5.42	1.67	2.50	0.83	1.53
Small Airway Epithelial Cells, donor2	11334-117F2	294.25	0.28	0.42	1.41	0.42	0.56
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	290.32	0.42	1.48	0.85	0.21	0.42
Small Airway Epithelial Cells, donor3	11406-118E2	353.47	1.42	0.60	1.20	0.22	0.37
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	379.25	2.16	0.00	2.47	0.62	1.23
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	235.45	1.33	0.00	1.78	0.00	0.67
Smooth Muscle Cells - Aortic, donor0	11210-116A4	243.95	0.59	1.18	0.00	0.00	0.59
Smooth Muscle Cells - Aortic, donor1	11283-116I5	173.48	0.88	2.43	0.00	0.66	0.44
Smooth Muscle Cells - Aortic, donor2	11360-117I1	265.80	0.00	0.79	0.79	0.39	0.39
Smooth Muscle Cells - Aortic, donor3	11432-118H1	254.17	1.55	0.00	0.77	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	100.08	0.00	1.00	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	273.21	2.13	1.06	1.06	0.80	0.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	306.99	1.33	2.44	2.66	0.44	1.99
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	338.00	0.64	0.26	1.92	0.90	0.64
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	262.10	1.30	1.30	1.30	0.33	0.33
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	320.72	1.18	0.30	0.89	0.59	0.59
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	244.01	0.57	0.43	1.14	0.14	0.14
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	68.49	0.16	0.49	0.49	0.00	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	121.47	0.91	0.00	0.91	0.30	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	216.45	1.26	0.51	0.00	0.76	0.25
Smooth Muscle Cells - Carotid, donor2	11362-117I3	153.02	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	268.94	1.91	0.00	2.38	0.95	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	251.74	0.74	1.03	1.77	0.29	0.74
Smooth Muscle Cells - Colonic, donor2	11320-117D6	221.91	1.51	0.65	1.08	0.86	0.43
Smooth Muscle Cells - Colonic, donor3	11396-118D1	272.47	0.73	0.21	0.84	0.84	0.10
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	280.28	0.62	1.24	0.31	0.00	0.15
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	211.26	0.00	1.08	2.16	1.08	1.08
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	229.52	0.30	0.90	0.60	0.60	0.60
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	90.81	0.00	0.00	0.00	0.34	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	179.91	0.24	0.39	1.10	0.24	0.24
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	393.41	21.03	2.42	1.01	1.51	1.61
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	303.78	1.14	1.14	1.59	1.14	1.37
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	203.48	1.21	1.21	0.00	1.21	0.60
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	483.75	0.53	1.59	1.32	0.53	0.79
Smooth Muscle Cells - Prostate, donor1	11257-116F6	383.10	3.60	0.93	0.67	0.40	0.53
Smooth Muscle Cells - Prostate, donor2	11335-117F3	227.52	3.88	0.50	1.13	0.50	0.50
Smooth Muscle Cells - Prostate, donor3	11465-119B7	209.53	2.28	0.00	1.01	0.76	1.01
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	481.87	3.32	1.51	1.36	0.00	0.45
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	192.79	2.25	0.75	0.75	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	236.48	10.34	14.21	28.43	6.46	1.29
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	236.72	1.40	0.93	0.47	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	274.66	2.02	1.51	0.50	0.50	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	211.23	1.25	1.25	1.25	0.31	0.31
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	77.58	0.29	0.00	0.29	0.00	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	565.82	0.17	0.92	0.58	0.33	0.25
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	249.46	0.93	0.00	0.93	0.93	0.47
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	255.02	2.01	1.01	0.43	0.29	0.29
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	297.79	0.25	1.02	2.29	0.25	0.51
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	214.55	0.38	0.75	0.56	0.38	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	420.91	0.70	0.84	1.82	0.28	0.14
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	424.64	0.17	1.51	0.84	0.50	0.67
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	21.90	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	255.43	1.96	1.96	0.24	0.00	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	290.55	5.30	0.88	0.66	0.22	0.66
Smooth Muscle Cells - Uterine, donor3	11466-119B8	135.76	0.88	0.88	2.05	0.29	0.59
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	115.45	1.94	0.39	0.58	0.39	0.19
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	160.52	3.70	2.12	2.38	1.32	1.59
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	150.27	10.79	0.37	2.98	1.12	1.49
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	205.54	4.67	1.80	1.44	0.36	0.72
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	181.13	1.14	1.42	0.57	0.28	0.28
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	253.65	1.58	0.79	3.15	1.18	0.39
Smooth muscle cells - airway, control, donor1	11966-126D4	121.13	3.30	0.25	2.29	0.76	1.02
Smooth muscle cells - airway, control, donor2	11967-126D5	111.81	2.80	1.20	0.40	0.80	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	120.80	3.76	1.25	1.67	1.25	0.84
Smooth muscle cells - airway, control, donor4	11969-126D7	135.22	2.29	0.92	1.38	0.00	1.38
Synoviocyte, donor1	11291-117A4	478.20	5.22	4.21	1.85	0.84	2.36
Synoviocyte, donor2	11368-117I9	238.86	1.84	1.68	1.84	1.01	1.01
Synoviocyte, donor3	11440-118H9	170.91	1.12	0.67	1.56	0.67	0.67
Trabecular Meshwork Cells, donor1	11532-120A2	197.96	0.00	0.36	0.71	0.00	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	61.44	0.00	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	95.86	0.00	0.00	0.46	0.23	0.23
Tracheal Epithelial Cells, donor1	11292-117A5	264.37	2.72	0.50	0.79	0.29	0.79
Tracheal Epithelial Cells, donor2	11369-118A1	172.79	0.77	0.00	0.39	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	150.61	0.57	0.00	0.00	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	664.95	13.41	4.18	2.34	1.11	1.23
Urethra, donor2	10319-105A4	422.63	0.00	1.80	0.00	1.80	1.80
Urothelial Cells, donor1	11520-119H8	131.24	1.33	0.00	0.53	0.00	0.53
Urothelial Cells, donor2	11600-120H7	85.32	1.20	0.00	0.40	0.00	0.00
Urothelial Cells, donor3	11681-122H7	101.54	0.00	0.46	0.23	0.00	0.00
Urothelial cells, donor0	11216-116B1	326.99	0.67	1.34	1.11	0.67	0.67
Whole blood (ribopure), donor090309, donation1	12179-129A1	1154.05	0.89	0.00	2.67	0.89	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	1209.45	2.86	0.00	1.43	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	529.13	0.00	2.05	2.05	0.00	1.37
Whole blood (ribopure), donor090325, donation1	12176-128I7	644.94	1.72	3.79	2.41	0.69	1.03
Whole blood (ribopure), donor090325, donation2	12177-128I8	639.71	1.16	0.58	1.16	2.91	2.91
Whole blood (ribopure), donor090612, donation1	12182-129A4	1036.03	2.08	0.00	1.04	1.04	3.12
Whole blood (ribopure), donor090612, donation2	12183-129A5	1077.49	0.00	0.00	0.92	0.00	0.92
Whole blood (ribopure), donor090612, donation3	12184-129A6	539.52	0.00	1.83	3.65	0.91	1.83
Wilms' tumor cell line:G-401	10809-111A8	221.56	0.62	0.86	0.74	0.74	0.62
Wilms' tumor cell line:HFWT	10597-108E3	173.37	0.00	1.76	0.00	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	248.87	1.12	0.00	1.96	1.68	1.12
achilles tendon, donor2	10292-104G4	231.45	6.20	0.00	2.07	2.07	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	253.17	0.76	2.04	3.57	0.51	0.25
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	471.31	0.46	0.70	1.39	0.93	0.46
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	300.09	0.83	1.78	0.24	0.71	0.12
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	328.17	0.00	2.45	3.54	0.54	2.72
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	465.76	0.84	0.28	7.59	1.41	0.84
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	215.08	0.63	0.42	0.21	0.00	0.21
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	227.30	0.54	1.63	2.18	0.54	0.54
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	270.11	0.44	0.44	1.32	0.44	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	194.79	1.23	0.41	3.27	1.23	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	147.94	0.00	1.55	0.39	0.78	0.39
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	234.05	0.74	0.37	4.23	1.84	0.74
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	265.24	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	455.47	1.16	0.23	7.44	0.70	0.70
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	382.92	0.00	0.78	6.21	2.33	2.07
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	318.25	0.58	0.88	5.55	0.88	0.88
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	195.66	0.00	1.86	0.93	0.00	0.46
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	526.40	0.41	2.06	3.29	1.65	1.65
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	69.68	0.00	0.31	2.46	0.00	0.31
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	171.11	2.13	0.00	0.85	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	214.13	0.00	0.30	0.91	0.00	0.30
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	210.14	0.24	0.72	0.72	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	226.75	0.45	0.45	2.90	0.89	0.22
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	761.82	0.67	1.33	2.00	1.33	2.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	148.66	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	355.94	0.00	1.88	3.01	0.38	0.38
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	239.44	0.00	0.00	0.00	0.00	0.44
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	286.79	0.00	0.00	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	312.74	0.47	0.24	2.12	0.47	0.00
adipose tissue, adult, pool1	10010-101C1	575.03	16.75	2.02	1.40	2.02	0.93
adipose, donor1	10184-103D4	360.64	12.90	4.10	5.86	15.83	0.59
adipose, donor2	10185-103D5	306.98	6.89	2.03	0.41	1.62	0.00
adipose, donor3	10186-103D6	412.24	17.43	3.27	4.36	2.72	1.63
adipose, donor4	10187-103D7	472.38	11.27	4.33	12.13	5.20	0.87
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	363.78	0.32	0.47	1.74	0.79	0.79
adrenal gland, adult, pool1	10081-102A9	134.59	0.00	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	269.35	2.67	1.33	1.33	0.40	0.40
alveolar cell carcinoma cell line:SW 1573	10708-109H6	155.07	0.71	2.86	0.36	0.36	0.00
amniotic membrane cells, donor1	12235-129G3	723.60	4.64	4.41	2.09	1.85	3.25
amniotic membrane cells, donor2	12236-129G4	381.38	4.40	0.34	3.38	1.69	1.35
amniotic membrane cells, donor3	12237-129G5	409.79	0.29	2.06	3.24	0.88	0.88
amygdala - adult, donor10196	10167-103B5	3310.75	17.79	26.09	34.39	15.42	9.49
amygdala, adult, donor10252	10151-102I7	2317.23	7.91	45.62	16.83	25.14	6.89
amygdala, newborn, donor10223	10360-105E9	1161.32	5.16	21.30	6.46	2.58	4.20
anaplastic carcinoma cell line:8305C	10428-106D5	325.20	3.31	2.04	0.76	0.76	1.02
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	516.48	1.10	1.54	5.74	3.09	1.76
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	315.00	1.00	3.67	1.34	0.33	0.67
aorta, adult, pool1	10052-101G7	543.88	3.33	2.94	3.92	1.37	0.98
appendix, adult	10189-103D9	459.53	5.82	1.55	1.55	0.78	0.78
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	330.87	2.75	2.75	2.75	0.34	1.38
artery, adult	10190-103E1	453.80	4.08	5.43	4.08	0.00	1.36
astrocytoma cell line:TM-31	10425-106D2	373.32	1.16	0.72	0.87	0.87	0.58
b cell line:RPMI1788	10427-106D4	163.13	0.45	0.30	0.74	0.15	0.59
basal cell carcinoma cell line:TE 354.T	10702-109G9	650.34	5.55	2.77	6.10	2.77	3.05
bile duct carcinoma cell line:HuCCT1	10432-106D9	405.16	1.59	1.39	1.09	0.50	0.50
bile duct carcinoma cell line:TFK-1	10496-107C1	132.73	0.84	1.67	1.51	0.17	0.17
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	172.25	0.56	0.00	0.00	1.12	0.00
bladder, adult, pool1	10011-101C2	603.07	13.15	4.13	2.72	1.63	1.20
blood, adult, pool1	10053-101G8	540.37	2.21	0.00	2.21	0.00	2.21
bone marrow stromal cell line:StromaNKtert	10686-109F2	444.44	0.00	1.71	1.71	0.86	0.00
bone marrow, adult	10192-103E3	423.79	1.35	0.67	6.07	0.00	2.02
brain, adult, donor1	10084-102B3	1583.73	16.40	15.38	22.55	4.10	8.20
brain, adult, pool1	10012-101C3	2592.64	30.73	36.08	12.14	7.80	7.57
brain, fetal, pool1	10085-102B4	1653.60	0.00	13.36	8.01	2.67	0.00
breast carcinoma cell line:MCF7	10482-107A5	384.54	0.99	3.63	2.31	0.66	0.99
breast carcinoma cell line:MDA-MB-453	10419-106C5	322.29	0.25	1.87	0.75	0.12	0.12
breast, adult, donor1	10080-102A8	379.45	8.84	0.63	1.89	1.26	1.26
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	257.76	0.89	1.52	1.65	0.64	0.51
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	256.96	1.55	3.40	2.47	0.62	0.93
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	875.75	3.68	1.84	10.82	3.22	5.76
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	226.11	0.00	2.42	3.63	0.00	0.73
carcinoid cell line:NCI-H1770	10703-109H1	351.69	2.35	5.17	3.29	0.47	1.41
carcinoid cell line:NCI-H727	10735-110B6	662.30	0.33	1.64	1.86	0.66	0.66
carcinoid cell line:SK-PN-DW	10719-109I8	148.62	0.63	1.90	0.63	0.95	0.63
carcinosarcoma cell line:JHUCS-1	10642-109A3	374.51	2.66	0.80	4.53	1.33	2.93
caudate nucleus - adult, donor10196	10177-103C6	2989.99	17.27	9.21	17.27	9.21	5.76
caudate nucleus, adult, donor10252	10164-103B2	2450.83	6.36	30.62	15.23	17.74	4.02
caudate nucleus, adult, donor10258	10379-105H1	2128.89	16.81	20.63	27.51	5.35	9.17
caudate nucleus, newborn, donor10223	10354-105E3	987.00	5.86	6.23	4.76	1.83	1.83
cerebellum - adult, donor10196	10173-103C2	3527.97	29.13	2.91	17.48	2.91	8.74
cerebellum, adult, donor10252	10166-103B4	3095.48	26.05	24.34	15.16	11.10	4.70
cerebellum, adult, pool1	10083-102B2	1497.75	6.90	11.38	15.18	4.48	4.83
cerebellum, newborn, donor10223	10357-105E6	930.75	4.98	4.15	9.96	2.49	6.64
cerebral meninges, adult	10188-103D8	2116.96	3.28	51.94	11.09	7.06	2.52
cerebrospinal fluid, donor2	10294-104G6	649.76	3.65	8.04	4.39	3.65	2.19
cervical cancer cell line:D98-AH2	10552-107I3	150.40	0.72	0.14	0.29	0.43	0.14
cervical cancer cell line:ME-180	10553-107I4	254.04	1.49	0.99	0.50	0.17	0.50
cervix, adult, pool1	10013-101C4	397.60	12.49	2.83	1.68	0.52	1.15
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	118.30	0.28	1.11	0.84	0.00	0.00
chondrosarcoma cell line:SW 1353	10700-109G7	142.38	0.00	0.00	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	396.19	10.81	0.99	2.24	0.87	0.75
choriocarcinoma cell line:SCH	10785-110H2	339.45	1.11	1.23	3.57	0.62	0.86
choriocarcinoma cell line:T3M-3	10618-108G6	235.52	0.47	0.24	0.71	0.24	0.71
chorionic membrane cells, donor1	12238-129G6	494.05	2.85	3.13	3.99	1.42	1.42
chorionic membrane cells, donor2	12239-129G7	350.30	8.45	0.70	2.09	1.29	1.39
chorionic membrane cells, donor3	12240-129G8	427.50	3.85	0.55	4.40	2.20	2.20
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	371.61	0.00	2.02	6.06	1.01	5.05
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	193.06	0.19	0.77	1.73	0.77	0.19
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	214.35	0.84	0.21	0.42	0.63	0.21
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	115.56	0.51	0.00	0.26	0.00	0.26
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	114.17	0.24	0.24	0.24	0.24	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	113.00	0.20	0.00	0.00	0.20	0.41
chronic myelogenous leukemia cell line:K562	10454-106G4	133.98	0.88	0.59	1.18	0.29	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	388.85	1.82	1.30	1.04	0.52	0.52
clear cell carcinoma cell line:JHOC-5	10638-108I8	171.44	1.14	0.69	2.51	1.83	0.91
clear cell carcinoma cell line:TEN	10636-108I6	313.18	2.26	0.87	2.26	1.04	1.04
colon carcinoma cell line:CACO-2	10513-107D9	692.81	2.93	3.29	1.46	0.55	0.37
colon carcinoma cell line:COLO-320	10420-106C6	293.42	0.76	0.00	0.76	0.00	0.76
colon, adult, donor1	10082-102B1	486.72	2.38	3.57	3.57	2.38	3.57
colon, adult, pool1	10014-101C5	1339.77	32.08	11.52	4.11	2.12	2.00
colon, fetal, donor1	10070-101I7	424.56	9.89	3.71	3.71	1.24	0.00
common myeloid progenitor CMP, donor1	12130-128D6	36.67	0.00	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	125.18	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	284.28	0.42	0.85	0.00	0.00	0.42
cord blood derived cell line:COBL-a 24h infection	10453-106G3	316.96	3.02	1.21	0.91	0.60	0.75
cord blood derived cell line:COBL-a untreated	10449-106F8	369.45	1.69	1.41	1.13	0.56	1.13
corpus callosum, adult, pool1	10042-101F6	1574.19	4.20	6.30	3.98	2.65	1.55
cruciate ligament, donor2	10295-104G7	279.61	1.62	0.81	1.62	0.81	0.00
diaphragm, fetal, donor1	10069-101I6	333.06	0.00	0.80	3.21	0.80	0.00
diencephalon, adult	10193-103E4	1936.47	15.36	30.00	10.56	2.88	3.60
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	177.26	0.23	1.38	4.82	0.69	1.38
ductal cell carcinoma cell line:KLM-1	10438-106E6	344.65	0.51	1.28	0.51	0.00	0.26
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	188.97	2.17	1.69	2.17	0.48	0.48
ductus deferens, adult	10196-103E7	514.79	2.49	4.98	1.99	1.99	1.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	426.31	2.88	4.32	1.44	0.00	1.44
duodenum, fetal, donor1, tech_rep2	10071-101I8	690.77	2.94	0.74	8.09	2.21	5.89
dura mater, adult, donor1	10041-101F5	487.84	2.97	1.32	0.91	0.33	0.41
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	206.53	6.44	0.89	0.44	0.67	0.44
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	287.88	4.30	1.15	0.43	0.14	0.86
embryonic pancreas cell line:1B2C6	10604-108F1	141.82	0.00	0.00	0.00	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	180.72	1.51	0.91	0.61	0.00	0.61
embryonic pancreas cell line:1C3IKEI	10606-108F3	134.61	0.00	0.62	0.31	0.31	0.00
embryonic pancreas cell line:2C6	10603-108E9	199.65	0.00	2.63	1.31	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	127.71	0.67	0.67	0.34	0.34	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	320.97	0.36	0.91	3.26	0.91	1.09
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	567.67	3.06	1.61	7.88	1.29	3.70
epidermoid carcinoma cell line:A431	10426-106D3	252.89	0.78	1.78	0.78	0.33	0.44
epidermoid carcinoma cell line:Ca Ski	10431-106D8	674.10	0.99	1.65	1.65	0.66	0.44
epididymis, adult	10197-103E8	520.14	10.05	4.81	2.93	3.14	2.93
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	245.54	0.89	1.42	1.60	0.89	0.35
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	126.62	0.00	0.00	0.39	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	322.64	1.44	1.31	2.75	0.13	0.92
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	244.28	1.08	0.39	1.28	0.30	0.89
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	334.86	1.46	0.67	2.13	0.90	1.46
esophagus, adult, pool1	10015-101C6	668.28	12.00	4.67	1.59	2.02	2.02
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	610.78	2.13	1.50	1.00	0.50	0.63
eye - muscle inferior rectus, donor1	10272-104E2	222.14	0.00	4.83	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	345.09	0.00	0.00	0.00	4.21	0.00
eye - muscle medial, donor2	10299-104H2	242.58	0.00	1.49	1.49	0.00	0.00
eye - muscle superior, donor2	10297-104G9	405.86	0.00	2.29	3.44	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	228.81	0.00	2.91	1.46	0.00	0.00
eye, fetal, donor1	10054-101G9	478.98	2.29	3.31	3.05	2.03	1.78
fibrosarcoma cell line:HT-1080	10758-110E2	176.44	0.90	0.90	1.03	0.51	0.38
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	221.75	1.90	0.71	1.42	0.24	0.71
frontal lobe, adult, pool1	10040-101F4	3723.78	6.94	22.80	8.73	3.66	3.47
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	248.01	1.20	0.30	3.30	2.70	0.30
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	174.73	0.55	0.64	0.27	0.00	0.18
gall bladder, adult	10198-103E9	405.61	3.62	3.14	2.41	1.21	0.00
gamma delta positive T cells, donor1	11937-126A2	1367.37	5.91	7.52	4.83	2.68	1.61
gamma delta positive T cells, donor2	11938-126A3	1239.24	4.11	10.46	7.84	1.87	1.87
gastric adenocarcinoma cell line:MKN1	10614-108G2	247.55	1.27	1.48	5.70	1.90	1.48
gastric adenocarcinoma cell line:MKN45	10612-108F9	616.42	0.77	2.51	4.06	0.39	0.58
gastric cancer cell line:AZ521	10549-107H9	228.39	0.16	0.33	0.49	0.16	0.00
gastric cancer cell line:GSS	10560-108A2	129.96	0.00	0.92	2.75	0.92	0.92
gastrointestinal carcinoma cell line:ECC12	10615-108G3	304.76	1.14	0.91	2.74	0.23	1.37
giant cell carcinoma cell line:LU65	10487-107B1	127.13	0.34	0.92	0.34	0.00	0.34
giant cell carcinoma cell line:Lu99B	10433-106E1	279.36	0.98	0.98	0.56	0.14	0.56
glassy cell carcinoma cell line:HOKUG	10688-109F4	241.94	0.25	1.00	2.74	0.25	1.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	251.21	0.21	1.48	0.95	0.53	0.63
glioblastoma cell line:A172, tech_rep2	10444-106F3	250.26	0.14	1.54	0.98	0.56	0.42
glioblastoma cell line:T98G	10485-107A8	150.55	0.11	1.21	0.99	0.22	0.33
glioma cell line:GI-1	10413-106B8	104.26	2.34	0.29	0.59	0.29	0.00
globus pallidus - adult, donor10196	10175-103C4	1913.39	8.02	13.85	11.66	5.10	0.73
globus pallidus, adult, donor10252	10161-103A8	1513.87	9.76	23.68	8.06	9.28	2.69
globus pallidus, adult, donor10258	10367-105F7	1200.80	4.11	28.75	50.66	15.06	9.58
globus pallidus, newborn, donor10223	10364-105F4	807.90	6.40	6.93	3.20	2.13	3.73
granulocyte macrophage progenitor, donor1	12131-128D7	122.36	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	163.93	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	188.16	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	205.76	0.00	1.28	1.28	0.00	0.32
hIPS +CCl2, biol_rep1	14383-156B9	529.82	5.05	0.46	2.30	0.46	1.38
hIPS +CCl2, biol_rep2	14384-156C1	551.00	1.37	0.91	8.23	0.91	1.37
hIPS +CCl2, biol_rep3	14385-156C2	564.87	1.93	0.00	5.15	0.64	0.64
hIPS, biol_rep1	14380-156B6	674.09	0.00	0.00	2.87	0.00	0.00
hIPS, biol_rep2	14381-156B7	566.53	1.37	0.00	0.69	0.69	0.00
hIPS, biol_rep3	14382-156B8	1913.41	4.41	7.72	16.55	6.62	2.21
hairy cell leukemia cell line:Mo	10712-109I1	263.78	1.15	1.72	4.31	0.86	1.15
heart - mitral valve, adult	10205-103F7	596.44	1.49	2.09	3.89	2.09	2.09
heart - pulmonic valve, adult	10206-103F8	594.59	1.83	2.61	2.88	1.05	0.78
heart - tricuspid valve, adult	10207-103F9	356.37	0.83	5.00	1.67	1.67	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	310.37	0.61	1.43	3.47	1.43	0.61
heart, adult, diseased, donor1	10051-101G6	397.73	0.85	2.13	8.94	2.98	2.13
heart, adult, pool1	10016-101C7	644.40	1.61	12.42	1.61	0.23	0.23
heart, fetal, pool1	10046-101G1	525.11	1.64	1.44	0.41	0.51	0.31
hepatic mesenchymal tumor cell line:LI90	10778-110G4	247.74	0.93	0.62	0.00	0.31	0.31
hepatoblastoma cell line:HuH-6	10633-108I3	265.19	0.00	1.19	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	339.89	1.77	0.33	1.55	0.33	0.55
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	331.35	2.67	0.36	2.18	0.36	0.61
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	340.04	2.12	0.30	0.81	0.40	0.40
hepatoma cell line:Li-7	10484-107A7	205.19	1.78	1.00	0.89	0.00	0.33
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	521.19	0.40	1.11	2.81	0.90	0.60
hippocampus - adult, donor10196	10169-103B7	3014.05	17.03	34.07	20.82	17.98	7.57
hippocampus, adult, donor10252	10153-102I9	2061.82	12.45	40.82	14.90	27.35	3.27
hippocampus, adult, donor10258	10374-105G5	2873.67	6.47	3.98	31.37	10.46	3.49
hippocampus, newborn, donor10223	10363-105F3	1727.85	11.98	23.97	7.05	4.58	0.35
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	458.98	5.49	9.16	9.77	6.10	1.22
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	437.28	5.50	2.16	3.53	1.18	1.57
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	367.64	8.63	1.78	4.06	1.52	3.55
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	287.01	20.30	2.26	0.56	3.95	2.26
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	316.83	39.76	2.07	10.84	7.23	8.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	325.33	29.23	1.90	3.04	3.42	3.42
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	455.74	31.82	2.92	2.92	4.67	5.26
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	593.29	41.36	1.51	3.66	6.68	3.45
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	462.53	31.28	2.92	2.09	1.25	2.92
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	653.07	28.65	4.50	3.32	0.71	2.37
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	590.96	40.34	5.30	5.63	5.30	2.73
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	602.61	24.91	6.06	0.67	2.02	2.02
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	358.04	5.79	1.56	4.07	2.35	1.41
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	338.99	14.74	0.98	9.83	6.88	5.40
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	301.97	3.49	4.36	2.62	4.36	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	297.06	18.90	1.53	2.48	3.25	2.67
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	282.58	14.39	0.44	1.74	2.62	1.31
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	191.91	9.50	2.50	3.50	4.50	1.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	258.10	17.14	1.32	2.83	2.26	2.83
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	275.10	20.01	1.36	1.82	1.82	1.82
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	254.35	11.90	4.39	1.25	2.51	0.94
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	364.82	18.62	1.80	4.41	4.57	2.29
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	372.18	17.13	3.48	1.45	3.48	2.61
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	302.51	15.84	5.08	1.79	2.69	1.79
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	420.66	10.72	2.03	5.36	1.48	2.22
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	437.34	9.13	0.86	2.85	2.28	2.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	403.00	7.35	3.27	4.49	3.67	1.63
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	314.06	20.42	1.06	5.28	6.34	2.82
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	273.35	19.64	0.63	2.22	5.70	2.85
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	256.32	17.55	1.51	2.12	3.33	1.82
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	355.78	13.96	2.07	0.52	0.52	0.52
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	310.83	13.95	0.00	0.00	1.33	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	249.86	14.62	1.28	1.28	0.51	0.77
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	354.84	15.08	2.05	3.83	2.81	2.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	463.42	11.36	3.03	1.51	1.51	2.27
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	289.35	17.14	3.70	1.68	3.36	1.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	448.48	10.87	1.21	2.42	1.69	2.17
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	366.33	17.38	3.57	5.79	4.90	2.67
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	355.12	10.73	3.90	3.41	1.95	1.46
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	377.13	14.98	1.22	3.06	3.67	1.53
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	1109.36	42.29	19.52	29.28	58.56	6.51
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	317.04	26.81	6.62	4.30	8.27	3.31
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	602.03	25.18	1.64	3.83	4.38	3.83
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	467.19	28.95	1.45	1.45	3.62	2.53
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	408.90	29.89	2.49	2.14	6.76	2.49
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	507.19	15.51	3.58	3.58	3.58	2.39
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	615.10	30.34	2.17	2.57	3.93	2.57
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	355.87	12.66	4.58	2.96	2.96	2.42
immature langerhans cells, donor1	11904-125F5	462.02	0.73	1.45	1.45	0.73	0.97
immature langerhans cells, donor2	11905-125F6	430.92	4.75	0.79	0.79	0.00	0.00
insula, adult, pool1	10039-101F3	3856.50	6.91	23.85	8.52	3.03	5.68
keratoacanthoma cell line:HKA-1	10791-110H8	90.39	0.33	0.33	0.98	0.33	0.00
kidney, adult, pool1	10017-101C8	549.80	3.80	3.30	2.70	1.50	1.00
kidney, fetal, pool1	10045-101F9	317.67	0.78	0.78	0.35	0.28	0.35
large cell lung carcinoma cell line:IA-LM	10509-107D5	395.39	1.42	0.85	0.57	0.71	0.43
large cell lung carcinoma cell line:NCI-H460	10839-111E2	992.44	5.53	8.85	10.51	3.46	4.01
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	212.49	0.37	1.47	0.73	0.00	0.37
left atrium, adult, donor1	10079-102A7	392.84	8.17	1.63	4.90	3.27	0.00
left ventricle, adult, donor1	10078-102A6	411.60	3.03	1.52	2.53	1.01	0.00
leiomyoblastoma cell line:G-402	10721-110A1	201.65	0.00	0.27	0.00	0.00	0.00
leiomyoma cell line:10964C	10569-108B2	205.85	6.47	1.08	4.31	0.36	1.44
leiomyoma cell line:15242A	10570-108B3	170.11	1.09	1.63	1.63	0.54	2.72
leiomyoma cell line:15425	10571-108B4	265.88	5.83	2.19	5.10	1.21	2.91
leiomyosarcoma cell line:Hs 5.T	10722-110A2	330.17	0.00	0.00	0.00	0.00	6.35
lens epithelial cell line:SRA 01/04	10647-109A8	61.69	0.00	0.00	0.00	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	220.41	0.24	0.59	0.94	0.12	0.35
liposarcoma cell line:KMLS-1	10782-110G8	1281.23	6.40	3.59	5.31	3.44	3.59
liposarcoma cell line:SW 872	10726-110A6	284.37	0.49	0.61	1.22	0.24	0.37
liver, adult, pool1	10018-101C9	388.46	13.29	2.11	1.94	0.97	1.30
liver, fetal, pool1	10086-102B5	101.60	0.00	0.00	0.00	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	1430.83	5.40	12.69	7.87	7.73	3.21
locus coeruleus, adult, donor10252	10165-103B3	1302.01	5.17	21.78	8.30	8.12	4.24
locus coeruleus, adult, donor10258	10375-105G6	928.80	6.49	18.62	38.09	11.57	8.46
locus coeruleus, newborn, donor10223	10362-105F2	737.34	22.71	12.62	9.25	1.68	4.63
lung adenocarcinoma cell line:A549	10499-107C4	245.65	0.28	1.80	0.55	0.28	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	108.24	0.00	0.69	0.00	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	218.02	0.40	0.13	0.53	0.13	0.13
lung, adult, pool1	10019-101D1	559.45	16.18	2.13	2.24	1.18	1.42
lung, fetal, donor1	10068-101I5	989.22	2.28	0.00	1.14	0.86	0.86
lung, right lower lobe, adult, donor1	10075-102A3	453.63	26.58	2.29	5.50	0.46	3.21
lymph node, adult, donor1	10077-102A5	275.02	4.73	1.42	3.79	1.42	1.42
lymphangiectasia cell line:DS-1	10727-110A7	186.96	0.22	0.66	0.00	0.22	0.44
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	129.80	0.30	0.15	0.91	0.00	0.60
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	287.13	0.00	3.40	0.85	0.00	0.85
mature adipocyte, donor1	12231-129F8	726.81	0.89	6.66	1.33	0.00	0.44
mature adipocyte, donor2	12232-129F9	888.22	3.11	7.68	2.28	0.62	0.21
mature adipocyte, donor3	12233-129G1	701.94	1.19	3.56	1.90	0.24	0.47
mature adipocyte, donor4	12234-129G2	677.26	1.84	3.95	1.84	0.53	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	225.87	1.43	0.48	0.71	0.00	0.24
medial frontal gyrus - adult, donor10196	10170-103B8	3654.82	16.92	19.18	27.07	12.41	11.28
medial frontal gyrus, adult, donor10252	10150-102I6	2536.44	10.48	28.69	10.48	15.82	5.70
medial frontal gyrus, adult, donor10258	10368-105F8	2327.70	13.66	20.97	27.96	9.53	5.08
medial frontal gyrus, newborn, donor10223	10352-105E1	2059.94	4.26	35.82	30.71	9.38	5.97
medial temporal gyrus - adult, donor10196	10183-103D3	2846.83	23.46	21.77	65.31	32.23	39.32
medial temporal gyrus, adult, donor10252	10156-103A3	2290.12	9.76	34.80	14.01	25.47	5.31
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	2115.03	7.71	7.71	13.48	5.78	1.93
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	9315.50	57.41	990.40	875.57	660.27	157.89
medial temporal gyrus, newborn, donor10223	10353-105E2	1873.27	5.74	21.89	8.26	3.95	1.79
medulla oblongata - adult, donor10196	10174-103C3	1172.70	4.54	11.03	10.38	4.54	2.60
medulla oblongata, adult, donor10252	10155-103A2	1297.26	6.19	8.05	4.18	4.49	2.17
medulla oblongata, adult, pool1	10038-101F2	1575.98	1.55	8.73	3.10	1.39	1.14
medulla oblongata, newborn, donor10223	10361-105F1	679.78	4.51	11.80	4.17	2.43	2.08
medulloblastoma cell line:D283 Med	10838-111E1	248.65	0.89	0.22	1.55	0.00	0.22
medulloblastoma cell line:ONS-76	10759-110E3	170.33	0.37	0.37	0.61	0.49	0.12
melanoma cell line:COLO 679	10514-107E1	267.22	4.60	1.87	1.29	0.29	1.01
melanoma cell line:G-361	10465-106H6	208.75	8.42	1.36	0.81	0.54	0.81
meningioma cell line:HKBMM	10691-109F7	170.41	0.54	0.36	2.71	0.72	1.09
merkel cell carcinoma cell line:MKL-1	10843-111E6	844.15	0.88	3.52	7.05	5.29	5.29
merkel cell carcinoma cell line:MS-1	10844-111E7	318.33	0.78	3.89	0.52	0.78	1.04
mesenchymal precursor cell - adipose, donor1	11747-123G1	391.87	1.53	1.23	1.99	0.46	1.07
mesenchymal precursor cell - adipose, donor2	11748-123G2	244.86	1.09	0.55	1.09	0.36	0.55
mesenchymal precursor cell - adipose, donor3	11749-123G3	366.90	2.07	0.00	2.48	0.41	1.24
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	346.83	1.26	0.70	2.81	0.84	0.56
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	250.53	0.96	0.58	1.35	1.16	1.54
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	344.96	0.69	1.39	3.47	0.69	3.47
mesenchymal precursor cell - cardiac, donor1	11752-123G6	195.32	2.23	0.34	0.86	0.17	0.34
mesenchymal precursor cell - cardiac, donor2	11753-123G7	260.40	2.30	0.35	1.61	0.58	0.58
mesenchymal precursor cell - cardiac, donor3	11754-123G8	365.55	0.80	0.40	1.72	0.66	1.59
mesenchymal precursor cell - cardiac, donor4	11755-123G9	432.26	1.08	1.22	2.84	0.41	1.22
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	353.38	1.00	0.28	2.99	0.43	0.85
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	122.19	1.98	0.33	0.66	0.00	0.33
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	370.28	1.11	0.42	2.08	0.97	0.42
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	439.15	0.70	1.75	2.09	1.40	0.35
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	365.45	1.63	0.20	2.65	1.43	0.82
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	258.09	1.44	0.72	1.80	1.44	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	207.31	0.41	0.10	0.41	0.83	0.52
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	210.89	2.05	0.46	3.65	0.91	0.46
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	625.98	1.26	0.42	6.29	2.52	2.94
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	316.21	1.20	0.45	2.09	0.45	0.90
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	315.81	1.23	0.09	2.63	0.35	0.79
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	227.15	0.74	0.00	1.84	0.74	0.37
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	234.36	1.43	2.29	2.00	1.14	1.43
mesenchymal stem cell line:Hu5/E18	10568-108B1	329.65	0.42	3.37	5.05	1.26	0.42
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	261.22	1.37	0.46	0.91	0.00	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	259.11	5.12	0.77	0.77	1.02	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	279.82	3.14	0.26	1.31	1.31	1.05
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	238.15	1.85	0.31	0.62	0.62	0.92
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	238.65	4.00	0.71	1.65	0.47	0.94
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	278.21	2.03	0.00	1.02	0.68	1.35
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	264.08	1.96	0.39	2.36	1.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	197.87	3.71	0.00	3.24	1.39	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	579.64	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	305.15	3.17	0.00	2.31	1.44	1.73
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	275.31	2.45	0.89	1.56	0.67	1.12
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	258.62	0.48	0.96	1.92	0.24	0.72
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	316.80	2.20	0.73	0.73	0.00	1.47
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	250.74	1.01	0.67	1.68	0.67	1.01
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	248.90	2.46	0.82	0.41	0.41	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	250.00	1.72	0.43	1.29	0.86	0.43
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	216.02	0.00	0.00	2.73	0.00	2.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	247.92	0.00	0.00	5.16	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	260.48	1.30	0.32	2.27	1.30	0.97
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	242.98	1.45	0.00	1.45	2.91	2.91
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	254.81	2.67	1.07	4.26	0.00	1.07
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	220.80	0.00	0.00	1.64	2.45	1.64
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	270.55	1.55	0.00	1.55	0.78	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	203.58	2.10	0.00	0.00	2.10	2.10
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	215.58	0.99	0.00	2.98	0.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	238.36	0.00	4.77	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	270.99	2.96	0.59	0.59	0.00	1.78
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	287.56	2.44	1.22	2.44	1.22	2.44
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	297.58	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	266.02	0.63	1.27	3.80	0.00	2.53
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	220.39	1.03	0.34	2.07	0.34	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	184.83	0.00	0.00	2.15	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	167.66	0.00	0.00	0.00	3.99	7.98
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	103.32	0.00	0.00	6.89	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	108.39	0.81	1.22	1.63	0.00	0.81
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	123.14	1.59	0.79	2.38	0.79	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	89.61	1.77	1.18	2.36	1.18	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	106.91	0.94	0.31	0.62	0.00	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	74.85	0.00	1.34	1.34	1.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	163.21	0.00	0.00	2.37	0.00	2.37
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	154.08	0.00	0.00	7.70	5.14	2.57
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	172.79	1.38	2.07	0.00	0.69	1.38
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	209.80	1.48	0.49	2.47	1.98	1.48
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	207.48	1.12	0.00	2.24	0.00	1.12
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	235.98	1.27	0.64	8.90	0.64	3.18
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	203.91	0.81	0.81	2.42	0.00	0.40
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	180.99	4.36	2.18	0.00	4.36	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	191.33	1.27	1.27	1.27	1.27	2.53
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	186.31	4.25	0.00	0.00	0.61	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	162.68	4.52	0.00	4.52	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	140.85	3.29	3.29	9.06	2.47	1.65
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	168.86	2.98	1.39	0.79	0.40	0.20
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	158.03	2.92	0.65	0.65	0.97	0.97
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	171.13	3.06	2.04	5.09	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	291.69	0.00	2.32	0.00	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	183.56	0.24	1.65	0.47	0.24	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	696.64	2.09	6.49	3.24	1.39	1.39
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	380.35	8.55	0.00	17.09	4.27	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	300.85	1.23	0.62	26.30	6.27	3.08
mesothelioma cell line:Mero-25	10850-111F4	139.12	0.68	0.68	1.59	0.00	0.00
mesothelioma cell line:Mero-41	10851-111F5	197.78	0.73	0.24	1.71	0.24	0.73
mesothelioma cell line:Mero-48a	10852-111F6	201.28	1.55	0.00	1.77	0.44	0.66
mesothelioma cell line:Mero-82	10853-111F7	177.66	0.53	0.79	3.68	0.26	0.26
mesothelioma cell line:Mero-83	10854-111F8	250.05	2.55	1.70	3.74	1.19	1.19
mesothelioma cell line:Mero-84	10855-111F9	401.66	2.53	3.29	4.04	1.01	0.76
mesothelioma cell line:Mero-95	10856-111G1	175.16	1.24	0.83	1.24	0.62	0.00
mesothelioma cell line:NCI-H2052	10847-111F1	258.74	0.66	1.16	4.80	0.66	0.17
mesothelioma cell line:NCI-H226	10846-111E9	251.76	0.90	1.09	3.98	0.18	0.72
mesothelioma cell line:NCI-H2452	10848-111F2	148.79	0.34	0.68	3.42	0.85	0.34
mesothelioma cell line:NCI-H28	10845-111E8	45.55	0.00	0.76	0.76	0.00	0.00
mesothelioma cell line:No36	10857-111G2	174.52	0.33	0.65	2.61	0.65	0.65
mesothelioma cell line:ONE58	10858-111G3	141.71	0.54	0.00	2.17	0.54	0.54
migratory langerhans cells, donor1	11901-125F2	472.32	0.96	1.34	2.49	0.77	1.54
migratory langerhans cells, donor2	11902-125F3	423.86	1.47	0.49	1.34	0.37	0.37
migratory langerhans cells, donor3	11903-125F4	483.16	0.90	1.08	1.08	0.36	0.90
mixed mullerian tumor cell line:HTMMT	10689-109F5	268.69	1.63	3.26	5.22	1.63	2.29
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	470.71	1.70	0.85	4.45	0.64	2.12
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	255.70	0.46	1.15	0.69	0.69	0.23
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	447.76	3.43	2.47	2.28	0.38	0.38
myelodysplastic syndrome cell line:SKM-1	10772-110F7	284.95	1.66	1.11	0.74	0.55	0.74
myeloma cell line:PCM6	10474-106I6	434.87	4.74	1.78	1.58	1.38	1.38
myxofibrosarcoma cell line:MFH-ino	10600-108E6	303.36	0.51	0.51	0.00	0.00	0.51
myxofibrosarcoma cell line:NMFH-1	10684-109E9	213.40	0.78	1.57	1.77	0.20	0.20
nasal epithelial cells, donor1, tech_rep1	12226-129F3	274.44	0.45	0.56	0.33	0.33	0.56
nasal epithelial cells, donor1, tech_rep2	12226-129F3	212.46	0.37	0.74	0.44	0.29	0.37
nasal epithelial cells, donor2	12227-129F4	464.22	0.55	0.55	3.31	0.55	0.00
neuroblastoma cell line:CHP-134	10508-107D4	298.85	0.69	2.53	0.46	1.15	0.00
neuroblastoma cell line:NB-1	10539-107G8	903.62	1.87	4.68	2.06	0.37	0.75
neuroblastoma cell line:NBsusSR	10607-108F4	502.13	2.11	3.59	4.85	1.05	2.11
neuroblastoma cell line:NH-12	10555-107I6	752.67	1.68	5.40	2.80	0.93	1.30
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	199.03	0.24	1.66	0.95	0.71	0.47
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	1051.96	8.39	11.88	9.98	4.12	4.43
neuroectodermal tumor cell line:TASK1	10774-110F9	136.05	0.20	0.81	0.60	1.01	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	69.30	0.00	0.00	0.00	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	302.10	0.80	1.33	0.53	0.53	0.27
neutrophil PMN, donor1	12133-128D9	401.62	0.00	14.87	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	1314.79	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	795.53	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	398.11	1.01	0.00	1.35	0.34	1.01
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	660.42	1.60	1.60	0.80	0.00	0.80
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	281.49	3.53	0.96	4.17	1.92	0.64
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	256.72	0.79	2.63	1.05	0.26	0.79
nucleus accumbens, adult, pool1	10037-101F1	3288.27	6.84	14.44	8.16	3.75	2.91
occipital cortex - adult, donor10196	10172-103C1	3801.41	20.60	2.06	20.60	12.36	2.06
occipital cortex, adult, donor10252	10163-103B1	2005.48	13.42	41.33	11.00	28.45	4.03
occipital cortex, newborn, donor10223	10355-105E4	2288.11	6.55	16.74	9.46	2.55	2.55
occipital lobe, adult, donor1	10076-102A4	2442.67	47.76	38.57	25.19	13.12	17.06
occipital lobe, fetal, donor1	10073-102A1	1673.92	6.87	10.73	17.16	4.72	8.58
occipital pole, adult, pool1	10036-101E9	2206.93	3.47	10.41	3.47	1.66	1.26
olfactory region, adult	10195-103E6	2305.04	10.32	26.94	17.19	10.13	4.97
optic nerve, donor1	10277-104E7	1656.87	4.00	4.00	10.01	4.00	2.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	252.42	2.96	1.37	0.57	0.46	0.34
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	212.26	0.69	0.55	0.41	0.41	0.14
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	388.77	1.02	1.35	8.47	2.37	1.52
oral squamous cell carcinoma cell line:SAS	10544-107H4	186.78	0.81	0.58	2.08	0.35	0.35
osteoclastoma cell line:Hs 706.T	10704-109H2	189.02	0.29	1.76	0.88	0.59	0.59
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	593.30	0.00	4.67	1.87	0.93	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	339.51	0.85	1.06	0.64	0.64	0.42
ovary, adult, pool1	10020-101D2	332.81	9.43	0.79	0.52	0.35	0.44
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	283.60	0.73	0.92	0.92	0.55	0.55
pancreas, adult, donor1	10049-101G4	294.42	1.88	0.94	3.76	0.00	1.88
pancreatic carcinoma cell line:NOR-P1	10698-109G5	648.80	5.31	1.68	2.80	3.35	1.40
papillary adenocarcinoma cell line:8505C	10437-106E5	255.87	1.19	1.19	6.81	2.04	2.04
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	186.61	0.17	0.66	0.00	0.17	0.17
paracentral gyrus, adult, pool1	10035-101E8	3415.69	6.96	20.41	10.80	2.75	3.20
parietal cortex, adult, donor10258	10373-105G4	2315.06	4.40	8.81	38.90	8.07	10.28
parietal lobe - adult, donor10196	10171-103B9	2545.89	14.11	11.29	20.69	14.11	6.58
parietal lobe, adult, donor10252	10157-103A4	2315.92	11.12	30.21	12.26	21.95	3.42
parietal lobe, adult, pool1	10034-101E7	3199.18	5.99	18.59	8.55	4.05	3.26
parietal lobe, fetal, donor1	10072-101I9	1397.53	3.88	12.61	21.34	7.76	4.85
parietal lobe, newborn, donor10223	10356-105E5	1926.87	6.73	27.29	14.21	5.23	3.74
parotid gland, adult	10199-103F1	648.11	3.70	4.93	8.02	0.00	0.00
penis, adult	10200-103F2	513.48	4.30	3.76	3.76	2.69	2.15
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	57.08	0.37	0.19	0.56	0.19	0.19
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	214.75	1.46	0.29	2.19	0.58	0.29
pineal gland - adult, donor10196	10179-103C8	1524.20	6.45	3.87	1.29	3.87	0.00
pineal gland, adult, donor10252	10160-103A7	1465.73	5.33	5.33	4.15	4.15	1.18
pineal gland, adult, donor10258	10377-105G8	838.40	5.64	6.27	6.90	5.02	2.51
pituitary gland - adult, donor10196	10180-103C9	891.40	7.08	1.01	3.04	3.04	3.04
pituitary gland, adult, donor10252	10162-103A9	1146.07	3.65	2.08	5.73	2.61	1.04
pituitary gland, adult, donor10258	10378-105G9	612.89	5.11	2.55	11.07	1.70	4.26
placenta, adult, pool1	10021-101D3	636.31	3.44	2.37	2.26	0.86	0.75
plasma cell leukemia cell line:ARH-77	10840-111E3	187.12	0.26	1.72	1.72	0.13	0.79
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	135.41	0.47	0.31	0.31	0.16	0.47
pons, adult, pool1	10033-101E6	2592.95	4.99	15.84	6.11	2.58	4.22
postcentral gyrus, adult, pool1	10032-101E5	2723.27	6.19	24.50	8.46	3.05	3.23
promyelocytes/myelocytes PMC, donor1	12132-128D8	94.11	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	275.40	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	140.83	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	378.72	1.89	2.04	3.79	1.17	1.75
prostate cancer cell line:PC-3	10439-106E7	712.94	1.09	6.17	4.54	0.91	0.73
prostate, adult, pool1	10022-101D4	458.81	6.62	1.63	0.82	0.73	0.63
putamen, adult, donor10196	10176-103C5	3770.17	12.51	36.12	18.18	12.28	6.61
putamen, adult, donor10252	10152-102I8	1829.36	7.84	68.63	13.73	19.61	5.88
putamen, adult, donor10258, tech_rep1	10372-105G3	1773.63	9.84	5.46	21.86	13.11	4.37
putamen, adult, donor10258, tech_rep2	10372-105G3	2823.24	8.46	17.88	46.15	22.95	9.18
putamen, newborn, donor10223	10365-105F5	853.11	20.24	11.24	6.00	3.00	2.25
rectal cancer cell line:TT1TKB	10469-106I1	183.87	0.29	2.04	0.58	0.58	0.00
rectum, fetal, donor1	10067-101I4	570.31	1.39	1.39	4.17	1.39	4.17
renal cell carcinoma cell line:OS-RC-2	10411-106B6	110.03	0.21	0.42	1.27	0.00	0.42
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	49.29	0.00	0.00	0.41	0.41	0.00
retina, adult, pool1	10030-101E3	664.49	1.99	2.58	2.39	0.70	0.60
retinoblastoma cell line:Y79	10475-106I7	158.48	1.04	1.04	0.52	0.52	0.78
rhabdomyosarcoma cell line:KYM-1	10787-110H4	376.71	0.86	1.23	2.70	0.86	0.98
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	517.13	0.56	2.25	1.69	0.00	0.28
sacrococcigeal teratoma cell line:HTST	10695-109G2	241.00	0.76	2.27	0.00	1.52	0.00
salivary acinar cells, donor1	11771-123I7	153.93	0.65	0.32	1.78	0.32	0.00
salivary acinar cells, donor2	11772-123I8	157.93	0.96	0.00	1.51	0.55	0.96
salivary acinar cells, donor3	11773-123I9	154.92	0.00	0.00	1.32	0.00	0.00
salivary gland, adult, pool1	10093-102C3	668.04	1.14	0.00	1.72	1.14	0.57
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	202.01	1.35	0.59	0.67	0.08	0.17
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	213.12	1.41	1.18	0.71	0.00	0.12
seminal vesicle, adult	10201-103F3	540.18	6.35	5.82	6.35	2.65	3.70
serous adenocarcinoma cell line:JHOS-2	10639-108I9	240.01	0.49	1.21	1.94	0.24	0.97
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	303.72	0.25	1.26	1.01	1.51	0.25
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	454.60	1.00	1.00	4.01	2.01	2.01
serous cystadenocarcinoma cell line:HTOA	10693-109F9	341.44	0.67	0.94	3.49	0.67	1.07
signet ring carcinoma cell line:Kato III	10436-106E4	221.72	1.11	1.22	0.22	0.22	0.44
signet ring carcinoma cell line:NUGC-4	10483-107A6	280.89	1.03	1.29	0.65	0.39	0.52
skeletal muscle - soleus muscle, donor1	10282-104F3	672.45	2.13	2.13	4.26	2.84	1.42
skeletal muscle, adult, pool1	10023-101D5	646.46	13.55	6.00	1.56	0.96	0.84
skeletal muscle, fetal, donor1	10066-101I3	164.82	2.01	1.01	1.01	0.00	0.00
skin, adult, donor1	10074-102A2	284.98	6.79	6.79	6.79	0.00	0.00
skin, fetal, donor1	10065-101I2	339.60	5.68	1.89	1.89	2.52	1.89
small cell cervical cancer cell line:HCSC-1	10800-110I8	1529.87	7.34	10.01	10.34	3.67	4.34
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	533.33	1.89	2.21	5.67	1.58	1.89
small cell lung carcinoma cell line:DMS 144	10841-111E4	220.89	0.77	0.77	0.96	0.96	0.77
small cell lung carcinoma cell line:LK-2	10541-107H1	168.12	0.49	0.99	0.00	0.00	0.49
small cell lung carcinoma cell line:NCI-H82	10842-111E5	126.91	0.16	0.32	0.97	0.00	0.32
small cell lung carcinoma cell line:WA-hT	10562-108A4	617.36	2.62	3.27	2.40	0.00	0.87
small intestine, adult, pool1	10024-101D6	1403.69	24.01	5.14	2.75	3.34	3.82
small intestine, fetal, donor1	10064-101I1	536.60	1.97	2.21	5.41	1.72	2.21
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	589.84	4.62	4.62	14.36	3.59	5.64
smooth muscle, adult, pool1	10048-101G3	579.71	1.03	2.07	3.88	1.29	1.03
somatostatinoma cell line:QGP-1	10781-110G7	311.44	1.07	0.54	0.54	0.80	0.27
spinal cord - adult, donor10196	10181-103D1	1016.96	10.55	5.51	8.49	5.74	3.44
spinal cord, adult, donor10252	10159-103A6	971.88	7.49	3.94	3.94	2.37	1.18
spinal cord, adult, donor10258	10369-105F9	1083.35	3.46	4.15	12.45	5.53	4.84
spinal cord, fetal, donor1	10056-101H2	973.30	6.71	14.64	11.59	7.32	3.05
spinal cord, newborn, donor10223	10359-105E8	608.00	1.38	5.97	6.89	1.84	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	327.68	0.45	1.05	1.34	0.15	0.30
spleen, adult, pool1	10025-101D7	502.32	6.72	1.54	2.09	1.32	0.66
spleen, fetal, pool1	10044-101F8	305.19	0.87	0.79	0.32	0.08	0.00
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	150.09	0.41	0.52	1.14	0.21	0.10
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	230.51	1.14	1.33	0.95	0.38	0.38
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	322.89	2.10	1.05	6.64	1.40	0.70
squamous cell carcinoma cell line:T3M-5	10616-108G4	320.17	0.78	0.39	1.17	0.78	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	289.84	0.45	1.46	0.79	0.34	0.23
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	308.38	1.69	0.42	2.54	1.27	2.12
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	253.84	0.00	0.00	0.42	0.00	0.42
stomach, fetal, donor1	10062-101H8	438.94	0.00	2.14	1.07	0.00	0.00
submaxillary gland, adult	10202-103F4	448.91	2.85	2.28	3.42	0.57	3.42
substantia nigra - adult, donor10196	10178-103C7	3093.63	54.27	108.55	1845.32	379.92	217.10
substantia nigra, adult, donor10252	10158-103A5	1125.77	6.23	14.54	7.89	4.78	3.32
substantia nigra, adult, donor10258	10371-105G2	1871.41	5.17	7.24	10.86	5.69	5.69
substantia nigra, newborn, donor10223	10358-105E7	447.97	3.53	7.77	2.83	1.41	1.41
synovial sarcoma cell line:HS-SY-II	10441-106E9	231.33	1.60	2.29	0.69	0.23	0.46
temporal lobe, adult, pool1	10031-101E4	2063.06	4.24	20.18	6.36	2.71	2.80
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	1274.96	5.70	14.25	18.52	8.55	5.70
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	1376.63	5.27	10.99	17.14	2.20	6.59
tenocyte, donor1	11763-123H8	463.61	0.70	1.05	5.93	1.40	3.14
tenocyte, donor2	11765-123I1	270.87	0.00	1.53	2.29	1.53	1.91
tenocyte, donor3	11768-123I4	394.76	0.00	1.48	4.82	1.85	2.59
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	332.10	0.85	1.19	2.04	0.85	1.19
teratocarcinoma cell line:NCR-G1	10798-110I6	419.13	3.85	0.62	2.47	1.23	0.77
teratocarcinoma cell line:PA-1	10807-111A6	310.73	1.86	0.93	3.72	0.46	0.77
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	373.35	3.68	0.76	2.03	1.27	1.14
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	163.37	0.38	0.38	0.76	0.00	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	339.40	2.07	0.22	1.09	0.87	0.76
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	303.56	4.23	0.33	6.84	0.98	1.30
testis, adult, pool1	10026-101D8	575.95	48.43	2.79	2.36	1.72	2.36
testis, adult, pool2	10096-102C6	459.20	1.80	1.35	9.02	2.26	0.90
thalamus - adult, donor10196	10168-103B6	1888.92	9.94	22.08	7.73	5.52	5.52
thalamus, adult, donor10252	10154-103A1	1503.29	5.00	22.35	9.53	6.10	3.91
thalamus, adult, donor10258, tech_rep1	10370-105G1	3653.51	3.08	3.08	16.94	4.62	3.08
thalamus, adult, donor10258, tech_rep2	10370-105G1	1320.81	7.58	36.40	64.56	34.58	9.88
thalamus, newborn, donor10223	10366-105F6	960.78	6.33	24.16	9.21	3.45	2.30
throat, adult	10209-103G2	402.97	7.49	2.50	2.50	0.50	1.00
throat, fetal, donor1	10061-101H7	328.47	0.61	1.52	2.44	0.61	0.30
thymic carcinoma cell line:Ty-82	10803-111A2	133.95	0.20	0.20	0.60	0.00	0.79
thymus, adult, pool1	10027-101D9	324.09	9.15	0.30	1.29	0.50	0.80
thymus, fetal, pool1	10043-101F7	338.83	3.74	0.62	0.52	0.31	0.10
thyroid carcinoma cell line:KHM-5M	10776-110G2	506.18	2.79	0.27	3.59	0.93	1.86
thyroid carcinoma cell line:TCO-1	10783-110G9	286.23	0.56	1.12	3.63	0.84	0.70
thyroid, adult, pool1	10028-101E1	305.79	4.67	2.05	0.93	0.28	0.28
thyroid, fetal, donor1	10060-101H6	343.29	1.05	1.58	1.85	0.79	0.53
tongue epidermis (fungiform papillae), donor1	10288-104F9	258.69	0.00	0.00	0.00	0.00	0.00
tongue, adult	10203-103F5	387.24	5.58	1.86	3.95	1.40	2.33
tongue, fetal, donor1	10059-101H5	449.66	4.34	3.15	5.12	2.36	0.39
tonsil, adult, pool1	10047-101G2	461.81	1.10	0.70	0.60	0.90	0.80
trachea, adult, pool1	10029-101E2	534.47	5.81	1.72	1.39	0.74	0.25
trachea, fetal, donor1	10058-101H4	331.22	1.54	2.31	3.46	0.38	1.15
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	365.26	2.13	1.42	5.31	1.06	0.35
transitional-cell carcinoma cell line:5637	10418-106C4	235.76	0.81	1.52	1.11	0.10	0.51
transitional-cell carcinoma cell line:JMSU1	10492-107B6	224.22	3.92	0.94	1.10	0.16	0.31
tridermal teratoma cell line:HGRT	10694-109G1	234.01	0.00	0.00	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	152.88	0.42	0.42	1.10	0.34	0.25
umbilical cord, fetal, donor1	10057-101H3	327.58	2.09	2.09	0.00	2.09	2.09
uterus, adult, pool1	10100-102D1	387.33	1.02	0.51	0.17	0.34	0.17
uterus, fetal, donor1	10055-101H1	333.78	0.51	1.54	2.56	1.02	0.51
vagina, adult	10204-103F6	347.65	1.29	0.00	0.65	0.65	0.00
vein, adult	10191-103E2	399.38	5.48	1.53	1.97	0.88	0.44
xeroderma pigentosum b cell line:XPL 17	10563-108A5	173.84	0.80	1.07	1.34	0.80	0.27